<SEC-DOCUMENT>0001104659-22-073264.txt : 20220622
<SEC-HEADER>0001104659-22-073264.hdr.sgml : 20220622
<ACCEPTANCE-DATETIME>20220622073104
ACCESSION NUMBER:		0001104659-22-073264
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220615
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220622
DATE AS OF CHANGE:		20220622

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Liquidia Corp
		CENTRAL INDEX KEY:			0001819576
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851710962
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39724
		FILM NUMBER:		221030001

	BUSINESS ADDRESS:	
		STREET 1:		419 DAVIS DRIVE, SUITE 100
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560
		BUSINESS PHONE:		919.328.4400

	MAIL ADDRESS:	
		STREET 1:		419 DAVIS DRIVE, SUITE 100
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2219020d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:lqda="http://liquidia.com/20220615">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_lqda_liquidia.com_20220615 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20220615_20220615 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001819576 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityCentralIndexKey">0001819576</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lqda-20220615.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-06-15to2022-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819576</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-15</xbrli:startDate>
        <xbrli:endDate>2022-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20220615__20220615_zsxMxmbMAImf"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_901_edei--DocumentPeriodEndDate_c20220615__20220615_zRcda4C0cGRi"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 15, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 14pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityRegistrantName_c20220615__20220615_zPn1CE29D5t4"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityRegistrantName">LIQUIDIA CORPORATION</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; width: 34%">&#160;</td>
    <td style="text-align: center; width: 33%">&#160;</td>
    <td style="text-align: center; width: 33%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20220615__20220615_zE5jOO0blLe8"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityFileNumber_c20220615__20220615_zYQXipR5XUPb"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityFileNumber">001-39724</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20220615__20220615_zdQIHeukEFk9"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityTaxIdentificationNumber">85-1710962</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</p></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20220615__20220615_zCVWLakttL27"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityAddressAddressLine1">419 Davis Drive</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20220615__20220615_zdNrjXIJEg85"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20220615__20220615_zZdWJMPUiBY9"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityAddressCityOrTown">Morrisville</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20220615__20220615_zzchaArDHOW6"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">North Carolina</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20220615__20220615_zqHWe6kBpdP7"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:EntityAddressPostalZipCode">27560</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90A_edei--CityAreaCode_c20220615__20220615_zhAzSMfIsiBc"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:CityAreaCode">919</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20220615__20220615_zhVxugkJQL69"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:LocalPhoneNumber">328-4400</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 3pt double; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; width: 100%"><span style="font: 10pt Times New Roman, Times, Serif">(Former name or former address, if changed since last report.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--WrittenCommunications_c20220615__20220615_zWPYnEzGkxQe"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span> <span style="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_906_edei--SolicitingMaterial_c20220615__20220615_zZo53BBSoTmc"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20220615__20220615_zYNID6xH9en9"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20220615__20220615_zwgvCGPbTfAl"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 42%"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--Security12bTitle_c20220615__20220615_zaMh4mwJPxq9"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:Security12bTitle">Common stock</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--TradingSymbol_c20220615__20220615_zNbQEdPgzijc"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" name="dei:TradingSymbol">LQDA</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--SecurityExchangeName_c20220615__20220615_zi5BB8A6fSh8"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20220615__20220615_zoVGqfXvOs48"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_905_edei--EntityExTransitionPeriod_c20220615__20220615_zQlCsHTpahS2"><ix:nonNumeric contextRef="From2022-06-15to2022-06-15" format="ixt:booleantrue" name="dei:EntityExTransitionPeriod">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in"><b>Item 5.02</b></td>
    <td style="text-align: justify"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Termination of Former Chief Medical Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective June&#160;15, 2022, Tushar Shah, M.D.&#8217;s employment
with Liquidia Corporation, a Delaware corporation (the &#8220;Company&#8221;) as the Company&#8217;s Chief Medical Officer terminated.
In connection with Dr.&#160;Shah&#8217;s termination of employment, the Company and Dr.&#160;Shah are working to finalize mutually agreeable
terms of a Severance Agreement and General Release.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in"><b>Item 8.01</b></td>
    <td><b>Other Events.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Appointment of New Chief Medical Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;7, 2022 (the &#8220;Appointment Date&#8221;),
Rajeev Saggar, M.D., was appointed by the Board of Directors (the &#8220;Board&#8221;) of Liquidia Corporation, a Delaware corporation
(the &#8220;Company&#8221;), as the Company&#8217;s Chief Medical Officer to be effective July&#160;18, 2022 (the &#8220;Effective Date&#8221;),
succeeding Dr.&#160;Shah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Dr.&#160;Saggar&#8217;s appointment,
on the Appointment Date, Liquidia Technologies,&#160;Inc., a Delaware corporation and wholly owned subsidiary of the Company (&#8220;Liquidia
Technologies&#8221;), and Dr.&#160;Saggar entered into an executive employment agreement (the &#8220;Employment Agreement&#8221;) pursuant
to which Dr.&#160;Saggar is entitled to an annual base salary of $475,000 and is eligible to receive a discretionary annual cash bonus
of up to 40% of his annualized base salary (the &#8220;Target Amount&#8221;). The cash bonus, to the extent earned, will not be pro-rated
for 2022. Furthermore, within 30 days of the Effective Date, Dr.&#160;Saggar will receive a $50,000 sign-on bonus which is subject to
repayment if, prior to the first anniversary of the Effective Date, Dr.&#160;Saggar&#8217;s employment is terminated for &#8220;Cause&#8221;
(as defined in the Employment Agreement) or Dr.&#160;Saggar resigns without &#8220;Good Reason&#8221; (as defined in the Employment Agreement).
Moreover, Dr.&#160;Saggar&#8217;s base salary may be increased from time to time by the Board and, notwithstanding anything to the contrary,
may also be reduced if the Board determines such reduction is necessary and justified by the Company&#8217;s financial condition and implements
an equal percentage reduction in the base salaries of all of the Company&#8217;s executive officers, provided that such reduction will
not be greater than 10% of his base salary. In accordance with the employment practices in North Carolina, Dr.&#160;Saggar is employed
by Liquidia Technologies on an at-will basis, meaning that either Liquidia Technologies or Dr.&#160;Saggar may terminate his employment
at any time without giving advance notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the Effective Date, pursuant to his Employment
Agreement, Dr.&#160;Saggar shall be granted a nonqualified stock option entitling the purchase up to 200,000 shares (the &#8220;Option&#8221;)
of common stock, $0.001 par value per share, of the Company (&#8220;Common Stock&#8221;), with an exercise price per share equal to the
Fair Market Value (as defined under the Liquidia Corporation 2022 Inducement Plan (the &#8220;Plan&#8221;)) of a share of Common Stock
on the date of grant. The Option (i)&#160;is subject to the terms of the Plan and the form of nonqualified stock option grant agreement,
and (ii)&#160;vests as follows: 25% of the shares of Common Stock underlying the Option will become vested and exercisable on the first
anniversary of the Effective Date and the balance of Option shares will become vested and exercisable in equal monthly installments over
the following 36 months, subject to Dr.&#160;Saggar&#8217;s continuous employment with the Company on each such vesting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, on the Effective Date, pursuant to
his Employment Agreement, Dr.&#160;Saggar shall be granted a number of restricted stock units (the &#8220;RSUs&#8221;) under the Liquidia
Corporation 2020 Long-Term Incentive Plan (the &#8220;LTIP&#8221;) equal to $350,000.00 divided by the Fair Market Value (as defined in
the LTIP) of a share of the Company&#8217;s Common Stock as of the Effective Date. The RSUs (i)&#160;are subject to the terms of the LTIP
and the form of award agreement, and (ii)&#160;vest as follows: 50% of the grant will become vested on the first anniversary of the Effective
Date and the balance will become vested in equal quarterly installments over the following two years, subject to Dr.&#160;Saggar&#8217;s
continuous employment with the Company on each such vesting date; provided, however, that the RSUs shall become fully vested in the event
that Dr.&#160;Saggar&#8217;s employment is terminated due to his death or &#8220;Disability&#8221; (as defined in the Employment Agreement)
or is terminated by the Company without Cause.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event Dr.&#160;Saggar&#8217;s employment
is terminated without Cause or Dr.&#160;Saggar resigns from his employment for Good Reason (as defined in the Employment Agreement), and
provided he signs and does not revoke a general release of claims in favor of the Company and its affiliates, among other things, then
he will be entitled to receive, subject to his compliance with certain obligations: (a)&#160;salary continuation for nine months (the
&#8220;Severance Period&#8221;); (b)&#160;any unpaid bonus for any full performance period completed prior to the termination date; and
(c)&#160;payment of the employer portion of the premiums required to continue his group healthcare coverage under the applicable provisions
of the U.S. Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), provided that he elects to continue and remains
eligible for these benefits, until the earliest of (i)&#160;the close of the Severance Period, (ii)&#160;the expiration of his eligibility
for the continuation coverage under COBRA or (iii)&#160;the date when he becomes eligible for substantially equivalent health insurance
coverage in connection with new employment. In the event Dr.&#160;Saggar&#8217;s employment is terminated for Cause or due to his death
or Disability or Dr.&#160;Saggar resigns from his employment for any reason other than a resignation for Good Reason, he will not receive
any severance compensation or benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event Dr.&#160;Saggar&#8217;s employment is terminated without
Cause or he resigns for Good Reason within 12 months following the effective date of a &#8220;Change in Control&#8221; (as defined in
the Plan), then Dr.&#160;Saggar will be eligible to receive, subject to his compliance with certain obligations, the same severance benefits
on the same conditions as if he had been terminated without Cause; provided, however, that (a)&#160;the Severance Period shall be increased
to 12 months, (b)&#160;Dr.&#160;Saggar will receive a bonus paid at the Target Amount, and (c)&#160;in the event that Dr Saggar&#8217;s
outstanding equity as of the closing of the Change in Control is assumed or continued (in accordance with its terms) by the surviving
entity in a Change in Control, then 100% of the unvested portion of such equity shall become vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&#160;Saggar, age 48, brings more than 20 years
of experience as a practicing pulmonologist and has authored more than 60 peer-reviewed publications with scientific interests including
pulmonary arterial hypertension (PAH) and pulmonary hypertension with interstitial lung disease (PH-ILD). Dr.&#160;Saggar has previously
served as Interim Chief of the Division of Pulmonary Critical Care at University of Arizona, College of Medicine, Phoenix and the Medical
Director of the Pulmonary Hypertension and Fibrosis Programs and Lung Transplant Program at Banner University Medical Center, Phoenix.
In his role at Banner Medical Center, he served as a Principal Investigator in the pivotal INSPIRE study of YUTREPIA initiated in 2018.
Just prior to joining Liquidia, Dr.&#160;Saggar served as Vice President of Clinical Development at Theravance Biopharma with oversight
of all phases of clinical development across respiratory disease portfolio, including pulmonary fibrosis, allograft rejection, asthma,
COPD, and COVID-19. Dr.&#160;Saggar received a M.D. degree from the University of California,&#160;Irvine. He completed his residency
in Internal Medicine and fellowship in Pulmonary&#160;&amp; Critical Care at the University of California,&#160;Irvine, as well as subspecialty
training in pulmonary hypertension and lung transplantation at University of California, San Diego and University of California, Los Angeles,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships between Dr.&#160;Saggar
and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to
be disclosed pursuant to Item 404(a)&#160;of Regulation S-K. Dr.&#160;Saggar was not appointed pursuant to any arrangement or understanding
between Dr.&#160;Saggar and any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The description of the terms of the Employment
Agreement is qualified in its entirety by the full text of the Employment Agreement filed herewith as Exhibit&#160;10.1 and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 0.75in"><b>Item 9.01</b></td>
    <td><b>Financial Statements and Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
No.</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 88%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td></tr>
  <tr style="text-decoration: none">
    <td style="text-decoration: none; vertical-align: top"><a href="tm2219020d1_ex10-1.htm"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="text-decoration: none; vertical-align: bottom"><span style="text-decoration: none">&#160;</span></td>
    <td style="text-decoration: none; vertical-align: top"><a href="tm2219020d1_ex10-1.htm"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Employment Agreement, dated as of June 13, 2022, by and between Liquidia Technologies, Inc. and Rajeev Saggar.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2022</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidia Corporation</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael Kaseta</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Kaseta</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: white"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: white">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LG4rDmGPDhVxiowhvlaXSXFrRlqnfpJ/ad0QQyAkN+deISZiTSvdIMNpUeRQYts1yiEUWCOjuaD/yDbbFPws8KqtY2XcsP7AjDyDnkmmydnfh89eW6xSiONQzkIZQTRPpYTDTgRfPSNT6wqN06oBZSo4MHWs0Sl+jQ6lepKh9jUkHZGtJuPtptEov0FGsYQ99epBfLOQ55kIJkMFYs10774xd+uohWWDrc+yI/rv4APci0kX -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2219020d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="" STYLE="height: 45px; width: 183px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This EXECUTIVE
EMPLOYMENT AGREEMENT (the &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into effective June&nbsp;13<SUP>th</SUP>, 2022 2022 (the &ldquo;<B><I>Effective
Date</I></B>&rdquo;), by and between Rajeev Saggar (&ldquo;<B><I>Executive</I></B>&rdquo;) and Liquidia Technologies,&nbsp;Inc., a Delaware
corporation (the &ldquo;<B><I>Company</I></B>&rdquo;). Each of the Company and Executive is a &ldquo;<B><I>Party</I></B>&rdquo; and, collectively,
they are the &ldquo;<B><I>Parties</I></B>.&rdquo;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company desires
to employ Executive and, in connection with such employment, to compensate Executive for Executive&rsquo;s personal services to the Company;
and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Executive desires
to provide personal services to the Company in return for certain compensation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, in
consideration of the mutual promises and covenants contained herein, the Parties agree to the following:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>EMPLOYMENT BY THE COMPANY</U></B>.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">1.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>At-Will
Employment</U></B>. Executive shall be employed by the Company beginning </FONT>on Monday, July&#8239;18<SUP>th</SUP>, 2022 (the &ldquo;<B><I>Start
Date</I></B>&rdquo;) on an &ldquo;at will&rdquo; basis, meaning either the Company or Executive may terminate Executive&rsquo;s employment
at any time, with or without cause or advance notice. Any contrary representations that may have been made to Executive shall be superseded
by this Agreement. This Agreement shall constitute the full and complete agreement between Executive and the Company on the &ldquo;at
will&rdquo; nature of Executive&rsquo;s employment with the Company, which may be changed only in an express written agreement signed
by Executive and a duly authorized officer of the Company. Executive&rsquo;s rights to any compensation following a termination shall
be only as set forth in Section&#8239;6.</P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">1.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Position</U></B>.
Subject to the terms set forth herein, the Company agrees to employ </FONT>Executive in the position of Chief Medical Officer, and
Executive hereby accepts such employment. Executive will report to the Chief Executive Officer (&ldquo;<B><I>CEO</I></B>&rdquo;)
and/or such Company officers or directors designated by the CEO.</P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">1.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Duties</U></B>.
Executive shall faithfully perform all duties of the Company related to </FONT>the position or positions held by Executive,
including but not limited to all duties set forth in this Agreement and/or in the Bylaws of the Company related to the position or
positions held by Executive and all additional duties that are reasonably prescribed from time to time by the CEO or other
designated officers or directors of the Company. Executive shall devote Executive&rsquo;s full business time and attention to the
performance of Executive&rsquo;s duties and responsibilities on behalf of the Company and in furtherance of its best interests.
Executive is expected to perform Executive&rsquo;s duties under this Agreement principally on a remote basis, but may be required to
work from the Company&rsquo;s corporate headquarters in North Carolina from time to time, as and to the extent necessary to carry
out his responsibilities. In addition, Executive shall make such business trips at the Company&rsquo;s expense to such places as may
be necessary or advisable for the efficient operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>419 Davis Drive, Suite&#8239;100, Morrisville,
North Carolina 27560<BR>
Phone: +1 919-328-4400 Fax: +1 919-328-4402</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&#8239;</TD><TD STYLE="width: 50%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="" STYLE="height: 45px; width: 182px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Company
Policies</U></B>. Executive shall comply with all Company policies, standards, rules&#8239;and regulations (a &ldquo;<B><I>Company Policy</I></B>&rdquo;
or collectively, the &ldquo;<B><I>Company Policies</I></B>&rdquo;) and all applicable government laws, rules&#8239;and regulations that
are now or hereafter in effect. Executive acknowledges receipt of copies of all written Company Policies that are in effect as of the
date of this Agreement. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from or are in conflict with
the Company&rsquo;s general employment policies or practices, this Agreement shall control.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>COMPENSATION</U></B>.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Salary</U></B>.
Executive shall receive a base salary of $475,000.00 on an annualized </FONT>basis, payable subject to standard federal and state
payroll withholding requirements in accordance with the Company&rsquo;s standard payroll practices (&ldquo;<B><I>Base
Salary</I></B>&rdquo;). Executive&rsquo;s Base Salary may be increased from time to time by the Board of Directors of the Company
(the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&ldquo;</I></B></FONT><B><I>Board<FONT STYLE="font-family: Times New Roman, Times, Serif">&rdquo;</FONT></I></B>).
Notwithstanding anything to the contrary, the Base Salary may be reduced if the Board determines such reduction is necessary and
justified by the financial condition of the Company and implements an equal percentage reduction in the base salaries of all of the
Company&rsquo;s executive officers, but in no event will such reduction be greater than ten percent (10%) of the Base Salary. A
reduction in Executive&rsquo;s Base Salary in accordance with the immediately preceding sentence shall not constitute a material
diminution in Base Salary as described in Section&#8239;6.4(b)&#8239;of this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Bonus</U></B>.
During the period Executive is employed with the Company, Executive </FONT>shall be eligible to earn a discretionary annual cash
bonus of up to 40% of Base Salary (&ldquo;<B><I>Target Award</I></B>&rdquo;), subject to review and adjustment by the Company in its
sole discretion, pursuant to the terms of the Liquidia Technologies,&#8239;Inc. Annual Cash Bonus Plan, as amended by the Company
from time to time (the &ldquo;<B><I>Bonus Plan</I></B>&rdquo;), or its successor plan. Any bonus, if earned, will be paid to
Executive within the time period set forth in the Bonus Plan. For the avoidance of doubt, Executive&rsquo;s bonus, to the extent
earned, shall not be pro-rated for the 2022 performance year.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&#8239;</TD><TD STYLE="width: 50%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Equity
Grants</U></B>. Upon employment and subject to approval of the Compensation Committee of the Board, as a material inducement to
Executive joining the Company, Executive will receive a nonqualified stock option to purchase 200,000 shares of the Company&rsquo;s
common stock (the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 13.5pt"><B><I>&ldquo;</I></B></FONT><B><I><FONT STYLE="font-size: 10pt">Option</FONT></I></B><FONT STYLE="font-size: 10pt">&rdquo;)
under the Liquidia Corporation 2022 Inducement Plan (the &ldquo;<B><I>Inducement Plan</I></B>&rdquo;) and applicable award
agreement, subject to the requirements under the inducement grant exception under Nasdaq Rule&#8239;5635(c)(4). The Option will be
issued with an exercise price per share of Common Stock underlying the Option equaling the Fair Market Value under the Inducement
Plan (of a share of Common Stock on the date of grant. The Option shall (i)&#8239;be granted under and subject to the terms of the
Plan and the form of nonqualified stock option grant agreement, and (ii)&#8239;be subject to the following vesting schedule: 25% of
the grant will become vested and exercisable or settled, as applicable, on the first anniversary of Executive&rsquo;s </FONT>start
date and the balance will become vested and exercisable or settled, as applicable, in equal monthly installments over the following
thirty-six (36) months, subject to Executive&rsquo;s continuous employment with the Company on each such vesting date. Furthermore,
upon employment and subject to approval of the Compensation Committee of the Board, the Executive will receive a number of
restricted stock units (the &ldquo;RSUs&rdquo;) under the Liquidia Corporation 2020 Long-Term Incentive Plan (the
 &ldquo;<B><I>Plan</I></B>&rdquo;) and applicable award agreement equal to $350,000.00 divided by the Fair Market Value (as defined
under the Plan) of a share of Common Stock on the Start Date, which RSUs shall be subject to the following vesting schedule: 50% of
the grant will become vested on the first anniversary of Executive&rsquo;s start date and the balance will become vested in equal
quarterly installments over the following two years, subject to Executive&rsquo;s continuous employment with the Company on each
such vesting date; provided, however, that the RSU shall become fully vested in the event that Executive&rsquo;s employment is
terminated due to his death or Disability or is terminated by the Company without Cause.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Sign-On
Bonus</U></B><U>.</U> As an incentive for Executive to commence employment with </FONT>the Company on the Effective Date and to
remain employed with the Company for at least one (1)&#8239;year thereafter, the Company agrees to pay to Executive a one-time,
sign-on bonus equal to $50,000.00 less standard payroll withholding requirements (the &ldquo;<B><I>Sign-On Bonus</I></B>&rdquo;).
The Company shall advance such Sign-On Bonus to Executive within thirty (30) days after the Executive&rsquo;s start date, subject to
Executive&rsquo;s obligation to repay the full amount of the Sign-On Bonus if, prior to the first anniversary of the
Executive&rsquo;s start date, Executive&rsquo;s employment is terminated by the Company for Cause or Executive resigns without Good
Reason. In the event Executive is required to repay the Sign-On Bonus as set forth herein, Executive agrees that the Company may
deduct, in accordance with applicable law, said amount from any payments the Company owes Executive, including but not limited to
Executive&rsquo;s final paycheck, bonus or other compensation, and any expense reimbursements, and Executive further agrees to pay
to the Company, within thirty (30) days of his termination date, any remaining unpaid balance of the Sign-On Bonus not covered by
such deductions. For purposes of clarity, Executive shall have no obligation to repay the Sign-On Bonus to the Company in the event
that Executive&rsquo;s employment is terminated due to his death or Disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Benefits</U></B>.
Executive will be eligible to participate on the same basis as similarly </FONT>situated employees in the Company&rsquo;s benefit
plans in effect from time to time during Executive&rsquo;s employment. All matters of eligibility for coverage or benefits under any
benefit plan shall be determined in accordance with the provisions of such plan. The Company reserves the right to change, alter, or
terminate any benefit plan in its sole discretion.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Expense
Reimbursement</U></B>. The Company shall reimburse Executive for all </FONT>customary and appropriate business-related expenses
actually incurred and documented in accordance with Company Policy, as in effect from time to time. For the avoidance of doubt, to
the extent that any reimbursements payable to Executive are subject to the provisions of Section&#8239;409A of the Code: (a)&#8239;any
such reimbursements will be paid no later than December&#8239;31 of the year following the year in which the expense was incurred,
(b)&#8239;the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year,
and (c)&#8239;the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&#8239;</TD><TD STYLE="width: 50%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-size: 10pt">3.
<B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>P</U></B></FONT><B><U>ROPRIETARY <FONT STYLE="font-size: 10pt">I</FONT>NFORMATION<FONT STYLE="font-size: 10pt">,&#8239;I</FONT>NVENTIONS<FONT STYLE="font-size: 10pt">,
N</FONT>ON<FONT STYLE="font-size: 10pt">-C</FONT>OMPETITION AND <FONT STYLE="font-size: 10pt">N</FONT>ON<FONT STYLE="font-size: 10pt">-S</FONT>OLICITATION
<FONT STYLE="font-size: 10pt">O</FONT>BLIGATIONS</U></B><FONT STYLE="font-size: 10pt">. As a condition of employment with the Company,
Executive agrees to execute and abide by a Confidentiality,&#8239;Inventions and Non-Competition Agreement (the &ldquo;<B><I>Confidential
Information Agreement</I></B>&rdquo;), which may be amended by the Parties from time to time without regard to this Agreement. The Confidential
Information Agreement contains provisions that are intended by the Parties to survive and do survive termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Permissible
Communications</U></B>. Notwithstanding anything to the contrary in the </FONT>Confidential Information Agreement, Executive
acknowledges that nothing in the Confidential Information Agreement shall be construed to prohibit Executive from (a)&#8239;filing a
charge or complaint with, or participating in any proceeding before, a government agency authorized to enforce and investigate
suspected violations of federal anti-discrimination laws, labor relations laws, occupational health and safety laws, wage and hour
laws, and such similar state or local laws; (b)&#8239;reporting possible violations of federal securities laws to the appropriate
government enforcing agency and make such other disclosures that are expressly protected under such laws, or (c)&#8239;responding
truthfully to inquiries from, or otherwise cooperating with, any governmental or regulatory investigation (the activities set forth
in clauses (a)&#8239;through (c)&#8239;are collectively referred to as the &ldquo;<B><I>Protected Activities</I></B>&rdquo;).
Executive understands that in connection with such Protected Activity, Executive is permitted to disclose documents or other
information as permitted by law, and without giving notice to, or receiving authorization from, the Company; <I>provided,
however</I>, that Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any
information that may constitute Proprietary Information under the Confidential Information Agreement to any parties other than the
appropriate government agencies. Executive further understands that &ldquo;Protected Activity&rdquo; does not include the disclosure
of any Company attorney-client privileged communications, and that any such disclosure without the Company&rsquo;s written consent
shall constitute a material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Defend
Trade Secrets Act</U></B>. Pursuant to the Defend Trade Secrets Act of 2016, </FONT>Executive acknowledges that Executive will not
have criminal or civil liability under any Federal or State trade secret law for the disclosure of a trade secret that (a)&#8239;is
made (i)&#8239;in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and
(ii)&#8239;solely for the purpose of reporting or investigating a suspected violation of law; or (b)&#8239;is made in a complaint or
other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if Executive files a lawsuit
for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to
Executive&rsquo;s attorney and may use the trade secret information in the court proceeding, if Executive (x)&#8239;files any
document containing the trade secret under seal and (y)&#8239;does not disclose the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>O</U></B></FONT><B><U>UTSIDE
<FONT STYLE="font-size: 10pt">A</FONT>CTIVITIES <FONT STYLE="font-size: 10pt">D</FONT>URING <FONT STYLE="font-size: 10pt">E</FONT>MPLOYMENT</U></B><FONT STYLE="font-size: 10pt">.
Except with the prior written consent of the Company, which shall not be unreasonably withheld, Executive will not, while employed by
the Company, undertake or engage in any other employment, occupation or business enterprise that would interfere with Executive&rsquo;s
responsibilities and the performance of Executive&rsquo;s duties hereunder, except for (i)&#8239;reasonable time devoted to volunteer
services for or on behalf of such religious, educational, non-profit and/or other charitable organization as Executive may wish to serve,
(ii)&#8239;reasonable time devoted to activities in the non-profit and business communities consistent with Executive&rsquo;s duties,
(iii)&#8239;performing qualified medical examinations in the State of California so long as Executive does not engage in such activity
more than eight (8)&#8239;hours per month, on average, and that such activity does not otherwise interfere with Executive&rsquo;s responsibilities
and the performance of Executive&rsquo;s duties hereunder, (iv)&#8239;covering hospital shifts up to twelve (12) hours per month in order
to maintain Executive&rsquo;s clinical skills so long as Executive does not prescribe any medications for pulmonary hypertension or other
conditions for which the Company markets, sells or promotes a product and that such activity does not otherwise interfere with Executive&rsquo;s
responsibilities and the performance of Executive&rsquo;s duties hereunder, and (v)&#8239;such other activities as may be specifically
approved by the Company. This restriction shall not, however, preclude Executive from owning less than one percent (1%) of the total
outstanding shares of a publicly traded company, or employment or service in any capacity with Affiliates of the Company. As used in
this Agreement, &ldquo;<B><I>Affiliates</I></B>&rdquo; means an entity under common management or control with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>N</U></B></FONT><B><U>O
<FONT STYLE="font-size: 10pt">C</FONT>ONFLICT WITH <FONT STYLE="font-size: 10pt">E</FONT>XISTING <FONT STYLE="font-size: 10pt">O</FONT>BLIGATIONS</U></B><FONT STYLE="font-size: 10pt">.
Executive represents that Executive&rsquo;s performance of all the terms of this Agreement and as an executive of the Company do not
and will not breach any agreement or obligation of any kind made prior to Executive&rsquo;s employment by the Company, including agreements
or obligations Executive may have with prior employers or entities for which Executive has provided services. Executive has not entered
into, and Executive agrees that Executive will not enter into, any agreement or obligation, either written or oral, in conflict herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>T</U></B></FONT><B><U>ERMINATION
<FONT STYLE="font-size: 10pt">O</FONT>F <FONT STYLE="font-size: 10pt">E</FONT>MPLOYMENT</U></B><FONT STYLE="font-size: 10pt">. The Parties
acknowledge that Executive&rsquo;s employment relationship with the Company is at-will. The provisions in this Section&#8239;govern the
amount of compensation, if any, to be provided to Executive upon termination of employment and do not alter this at-will status.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Termination
by the Company Without Cause</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have the right to terminate Executive&rsquo;s employment with the Company pursuant to this Section&#8239;6.1 at any time
without &ldquo;Cause&rdquo; (as defined in Section&#8239;6.2(b)&#8239;below) by giving notice as described in Section&#8239;7.1 of this Agreement.
A termination pursuant to Sections 6.3 and 6.5 below is not a termination without &ldquo;Cause&rdquo; for purposes of receiving the benefits
described in this Section&#8239;6.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Company terminates Executive&rsquo;s employment at any time without Cause and provided that such termination constitutes a
 &ldquo;separation from service&rdquo; (as defined under Treasury Regulation Section&#8239;1.409A-1(h)&#8239;a &ldquo;<B><I>Separation
from Service</I></B>&rdquo;), then Executive </FONT>shall be entitled to receive the Accrued Obligations (defined below) and,
subject to Executive&rsquo;s compliance with the obligations in Section&#8239;6.1(c)&#8239;below, then Executive shall also be
entitled to receive (collectively, the &ldquo;<B><I>Severance Benefits</I></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">an
amount equal to Executive&rsquo;s then current Base Salary for nine (9)&#8239;months (the &ldquo;<B><I>Severance Period</I></B>&rdquo;),
less all applicable withholdings and deductions, paid in equal installments beginning on the Company&rsquo;s first regularly scheduled
payroll date following the Release Effective Date (as defined in Section&#8239;6.1(c)&#8239;below), with the remaining installments occurring
on the Company&rsquo;s regularly scheduled payroll dates thereafter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">an
amount equal to the unpaid bonus (if any) that Executive would have earned pursuant to the Bonus Plan with respect to any Performance
Period (as defined in the Bonus Plan) completed prior to the termination date but for the employment requirement set forth in Section&#8239;6.3
of the Bonus Plan; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">payment
of the employer portion of the premiums required to continue Executive&rsquo;s group health care coverage under the applicable provisions
of the Consolidated Omnibus Budget Reconciliation Act of 1985 (&ldquo;<B><I>COBRA</I></B>&rdquo;), provided that Executive timely elects
to continue coverage under COBRA, until the earliest of (A)&#8239;the close of the Severance Period, (B)&#8239;the expiration of Executive&rsquo;s
eligibility for the continuation coverage under COBRA, or (C)&#8239;the date when Executive becomes eligible for substantially equivalent
health insurance coverage in connection with new employment (such period from the termination date through the earliest of (A), (B)&#8239;or
(C), the &ldquo;<B><I>COBRA Payment Period</I></B>&rdquo;). Notwithstanding the foregoing, if at any time the Company determines in its
sole discretion that the payment of the COBRA premiums would result in a violation of the nondiscrimination rules&#8239;of Section&#8239;105(h)(2)&#8239;of
the Code, or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care
Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing the COBRA premiums, the Company will
instead pay Executive on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA
premiums for that month, subject to applicable tax withholdings for the remainder of the COBRA Payment Period, regardless of whether Executive
elects COBRA coverage (the &ldquo;<B><I>Special Severance Payment</I></B>&rdquo;). Executive may, but is not obligated to, use such Special
Severance Payment toward the cost of COBRA premiums. If Executive becomes eligible for coverage under another employer&rsquo;s group health
plan or otherwise ceases to be eligible for COBRA during the COBRA Payment Period, Executive must immediately notify the Company of such
event, and all payments and obligations under this clause will cease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Executive
will be paid all of the Accrued Obligations on the Company&rsquo;s first payroll date after Executive&rsquo;s date of termination
from employment or earlier if required by law. Executive shall receive the Severance Benefits pursuant to
Section&#8239;6.1(b)&#8239;of this Agreement if: (i)&#8239;Executive signs and delivers to the Company an effective, general release of
claims in favor of the Company and its affiliates and representatives, in a form acceptable to the Company (the
 &ldquo;<B><I>Release</I></B>&rdquo;), by the 60th day following the termination date or such earlier date as set forth in the
Release, which cannot be revoked in whole or part (if applicable) by such date or such earlier </FONT>date as set forth in the
Release (the date that the Release can no longer be revoked is referred to as the &ldquo;<B><I>Release Effective
Date</I></B>&rdquo;); (ii)&#8239;if Executive holds any other positions with the Company, Executive resigns such position(s)&#8239;to
be effective no later than the date of Executive&rsquo;s termination date (or such other date as requested by the Board);
(iii)&#8239;Executive returns all Company property in proper order and condition, reasonable wear and tear excepted, (including, but
not limited to, all books, documents, papers, materials and any other property or assets relating to the business or affairs of the
Company which may be in Executive&rsquo;s possession or under his control but excluding copies of records related to
Executive&rsquo;s compensation from the Company and any equity ownership in the Company); (iv)&#8239;Executive complies with all
post-termination obligations under this Agreement and the Confidential Information Agreement; and (v)&#8239;Executive complies with
the terms of the Release, including without limitation any non-disparagement and confidentiality provisions contained in the
Release. To the extent that any Severance Benefits are deferred compensation under Section&#8239;409A of the Code, and are not
otherwise exempt from the application of Section&#8239;409A, then, if the period during which Executive may consider and sign the
Release spans two calendar years, the payment of Severance Benefits will not be made or begin until the later calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of this Agreement, &ldquo;<B><I>Accrued Obligations</I></B>&rdquo; are (i)&#8239;Executive&rsquo;s accrued but unpaid salary through
the date of termination, (ii)&#8239;any unreimbursed business expenses incurred by Executive payable in accordance with the Company&rsquo;s
standard expense reimbursement policies, and (iii)&#8239;benefits owed to Executive under any qualified retirement plan or health and welfare
benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Severance Benefits provided to Executive pursuant to this Section&#8239;6.1 is in lieu of, and not in addition to, any benefits to which
Executive may otherwise be entitled under any Company severance plan, policy or program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
damages caused by the termination of Executive&rsquo;s employment without Cause would be difficult to ascertain; therefore, the Severance
Benefits for which Executive is eligible pursuant to Section&#8239;6.1(b)&#8239;above in exchange for the Release is agreed to by the Parties
as liquidated damages, to serve as full compensation, and not a penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">6.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Termination
by the Company for Cause</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to Section&#8239;6.2(c)&#8239;below, the Company shall have the right to terminate Executive&rsquo;s employment with the Company at any
time for Cause by giving notice as described in Section&#8239;7.1 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;<B><I>Cause</I></B>&rdquo;
for termination shall mean that the Company has determined in its sole discretion that Executive has engaged in any of the
following: (i)&#8239;any material breach of the terms of this Agreement by Executive, or the willful failure of Executive to
diligently and properly perform Executive&rsquo;s material duties for the Company; (ii)&#8239;Executive&rsquo;s misappropriation or
unauthorized use of the Company&rsquo;s tangible or intangible property that causes or is likely to cause material harm to the
Company or its reputation, or material breach of the Confidential </FONT>Information Agreement or any other similar agreement
regarding confidentiality, intellectual property rights, non-competition or non-solicitation; (iii)&#8239;any material failure to
comply with the Company Policies or any other policies and/or directives of the Board; (iv)&#8239;Executive&rsquo;s use of illegal
drugs or any illegal substance, or Executive&rsquo;s use of alcohol in any manner that materially interferes with the performance of
Executive&rsquo;s duties under this Agreement; (v)&#8239;any (A)&#8239;dishonest or illegal action (including, without limitation,
embezzlement) by Executive, or (B)&#8239;other action, whether or not dishonest or illegal, by Executive, in either case which is
materially detrimental to the interest and well-being of the Company, including, without limitation, harm to its reputation;
(vi)&#8239;Executive&rsquo;s failure to fully disclose any material conflict of interest Executive may have with the Company in a
transaction between the Company and any third party which is materially detrimental to the interest and well-being of the Company;
(vii)&#8239;any adverse action or omission by Executive which would be required to be disclosed pursuant to public securities laws or
which would limit the ability of the Company or any entity affiliated with the Company to sell securities under any Federal or state
law or which would disqualify the Company or any affiliated entity from any exemption otherwise available to it; or
(viii)&#8239;become prohibited by law or any order from any regulatory body or governmental body from being an employee or director
of any company, firm or entity; <I>provided, however</I>, that prior to any termination of Executive for &ldquo;Cause,&rdquo; if the
grounds for such Cause are reasonably capable of cure by Executive, the Company shall provide Executive with written notice of the
grounds for Cause and provide Executive with ten (10)&#8239;business days in which to cure such Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event Executive&rsquo;s employment is terminated at any time for Cause, Executive will not receive Severance Benefits or any other
severance compensation or benefits, except that, pursuant to the Company&rsquo;s standard payroll policies, the Company shall pay to Executive
the Accrued Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">6.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Resignation
by Executive</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Executive
may resign from Executive&rsquo;s employment with the Company at any time by giving notice as described in Section&#8239;7.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event Executive resigns from Executive&rsquo;s employment with the Company for any reason (other than a resignation for Good Reason
as described in Section&#8239;6.4 below), Executive will not receive Severance Benefits or any other severance compensation or benefits,
except that, pursuant to the Company&rsquo;s standard payroll policies, the Company shall pay to Executive the Accrued Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">6.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Resignation
by Executive for Good Reason</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Provided
Executive has not previously been notified of the Company&rsquo;s intention to terminate Executive&rsquo;s employment, Executive may resign
from employment with the Company for Good Reason (as defined in Section&#8239;6.4(b)&#8239;below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;<B><I>Good
Reason</I></B>&rdquo; for resignation shall mean the occurrence of any of the following without Executive&rsquo;s prior consent:
(i)&#8239;a material diminution in Executive&rsquo;s authority, </FONT>duties or responsibilities; (ii)&#8239;a material diminution in
Executive&rsquo;s Base Salary; (iii)&#8239;a requirement that Executive report to an employee other than the CEO;
(iv)&#8239;Executive&rsquo;s employment is changed from being primarily remote employment to primarily in-office employment and
Executive&rsquo;s principal place of employment is established at a location that is more than fifty (50) miles from the
Executive&rsquo;s then-current residence; or (v)&#8239;the Company materially breaches its obligations under this Agreement. In
addition to any requirements set forth above, in order for any of the above events to constitute &ldquo;Good Reason,&rdquo;
Executive must (X)&#8239;inform the Company of the existence of the event within sixty (60) days of the initial existence of the
event, after which date the Company shall have no less than thirty (30) days to cure the event which otherwise would constitute
 &ldquo;Good Reason&rdquo; hereunder and (Y)&#8239;Executive must terminate his employment with the Company for such &ldquo;Good
Reason&rdquo; no later than ninety (90) days after the initial existence of the event which prompted Executive&rsquo;s termination.
Any actions taken by the Company to accommodate a disability of Executive or pursuant to the Family and Medical Leave Act shall not
be a Good Reason for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event Executive resigns from Executive&rsquo;s employment for Good Reason, and provided that such termination constitutes a Separation
from Service, then subject to Executive&rsquo;s compliance with the obligations in Section&#8239;6.1(c)&#8239;above, Executive shall be
eligible to receive the same Severance Benefits as described in Section&#8239;6.1 and on the same terms and conditions set forth in Section&#8239;6.1(c)&#8239;and
Section&#8239;6.1(e)&#8239;as if Executive had been terminated by the Company without Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
damages caused by the termination of Executive&rsquo;s employment for Good Reason would be difficult to ascertain; therefore, the Severance
Benefits for which Executive is eligible pursuant to Section&#8239;6.1(b)&#8239;above in exchange for the Release is agreed to by the Parties
as liquidated damages, to serve as full compensation, and not a penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">6.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Termination
by Virtue of Death or Disability of Executive.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event of Executive&rsquo;s death while employed pursuant to this Agreement, all obligations of the Parties hereunder shall terminate
immediately, and the Company shall, pursuant to the Company&rsquo;s standard payroll policies, pay to Executive&rsquo;s legal representatives
all Accrued Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to applicable state and federal law, the Company shall at all times have the right, upon written notice to Executive, to terminate
this Agreement based on Executive&rsquo;s Disability. Termination by the Company of Executive&rsquo;s employment based on
 &ldquo;<B><I>Disability</I></B>&rdquo; shall mean termination because a qualified medical doctor mutually acceptable to the Company
and Executive or Executive&rsquo;s personal representative has certified in writing that: (A)&#8239;Executive is unable, because of a
medically determinable physical or mental disability, to perform the essential functions of Executive&rsquo;s job, with or without a
reasonable accommodation, for more than one hundred and eighty (180) calendar days measured from the last full day of work; or
(B)&#8239;by reason of mental or physical disability, it is unlikely that Executive will be able, within one hundred and eighty (180)
calendar days, to resume the essential functions of Executive&rsquo;s job, with or without a reasonable accommodation, and to
otherwise discharge </FONT>Executive&rsquo;s duties under this Agreement. This definition shall be interpreted and applied
consistent with the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable law. In the event
Executive&rsquo;s employment is terminated based on Executive&rsquo;s Disability, Executive will not receive Severance Benefits or
any other severance compensation or benefit, except that, pursuant to the Company&rsquo;s standard payroll policies, the Company
shall pay to Executive the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">6.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Change
in Control Benefits.</U></B> In the event the Company (or any surviving or </FONT>acquiring corporation) terminates
Executive&rsquo;s employment without Cause or Executive resigns for Good Reason within twelve (12) months following the effective
date of a Change in Control (as defined under the Plan), then Executive shall be entitled to the Accrued Obligations and, provided
that Executive complies with the obligations in Section&#8239;6.1(c)&#8239;of this Agreement (including the requirement to provide an
effective Release), Executive shall be eligible to receive the same Severance Benefits as described in Section&#8239;6.1(b)&#8239;and
on the same conditions as if Executive had been terminated by the Company without Cause; <I>provided, however, </I>that (a)&#8239;the
Severance Period shall be increased to twelve (12) months; (b)&#8239;the bonus set forth in Section&#8239;6.1(b)(ii)&#8239;shall
instead be payable at the Target Amount; and (c)&#8239;in the event that Executive&rsquo;s outstanding equity as of the closing of
the Change in Control is assumed or continued (in accordance with its terms) by the surviving entity in a Change in Control, then
100% of the unvested portion of such equity shall become vested.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">6.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Cooperation
With Company After Termination of Employment</U></B>. Following </FONT>termination of Executive&rsquo;s employment for any reason
and for a period of one (1)&#8239;year thereafter, Executive agrees to cooperate (a)&#8239;with the Company in (i)&#8239;the defense of
any legal matter involving any matter that arose during Executive&rsquo;s employment with the Company, and (ii)&#8239;all matters
relating to the winding up of Executive&rsquo;s pending work and the orderly transfer of any such pending work to such other
employees as may be designated by the Company; and (b)&#8239;with all government authorities on matters pertaining to any
investigation, litigation or administrative proceeding pertaining to the Company. The Company will reimburse Executive for any
reasonable travel and out of pocket expenses incurred by Executive in providing such cooperation. The Company will also pay
Executive a per diem amount equal to Executive&rsquo;s Base Salary as of the date of termination divided by two hundred and thirty
(230) for each day or partial day that Executive devotes to fulfilling his obligation to cooperate under this Section&#8239;6.7,
unless Executive is then receiving continued payment of his Base Salary under 6.1(b)(ii), above. Following termination of
Executive&rsquo;s employment for any reason, and in the event of a failure by Executive (following reasonable efforts by the Company
to secure his voluntary cooperation) to resign from any position as officer or director of the Company, with such resignation to be
effective no later than the date of Executive&rsquo;s termination date (or such other date as requested by the Board), the Company
is hereby irrevocably authorized to appoint its then-current Chief Executive Officer to act in Executive&rsquo;s name and on his
behalf to execute any documents and to do all things reasonably necessary to effect such resignation. Further, Executive shall not,
at any time after termination of Executive&rsquo;s employment for any reason, represent himself as being an agent or representative
of the Company, unless expressly authorized in a written agreement executed by an authorized officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">6.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Application
of Section&#8239;409A</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">It
is intended that all of the severance payments payable under this Agreement satisfy, to the greatest extent possible, the exemptions from
the application of Section&#8239;409A of the Code and the regulations and other guidance thereunder and any state law of similar effect
(collectively, &ldquo;<B><I>Section&#8239;409A</I></B>&rdquo;) provided under Treasury Regulations Sections 1.409A-1(b)(4)&#8239;and 1.409A-1(b)(9),
and this Agreement will be construed in a manner that complies with Section&#8239;409A. If not so exempt, this Agreement (and any definitions
hereunder) will be construed in a manner that complies with Section&#8239;409A, and incorporates by reference all required definitions
and payment terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
preceding provisions shall not be construed as a guarantee by the Company of any particular tax effect to Executive under this Agreement.
The Company shall not be liable to Executive for any payment made under this Agreement which is determined to result in an additional
tax, penalty or interest under Section&#8239;409A, nor for reporting in good faith any payment as an amount includible in gross income
under Section&#8239;409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
severance payments will be made under this Agreement unless Executive&rsquo;s termination of employment constitutes a &ldquo;separation
from service&rdquo; (as defined under Treasury Regulation Section&#8239;1.409A-1(h)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of Section&#8239;409A (including, without limitation, for purposes of Treasury Regulations Section&#8239;1.409A-2(b)(2)(iii)),
Executive&rsquo;s right to receive any installment payments under this Agreement (whether severance payments or otherwise) shall be treated
as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered
a separate and distinct payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Company determines that the severance benefits provided under this Agreement constitutes &ldquo;deferred compensation&rdquo; under
Section&#8239;409A and if Executive is a &ldquo;specified employee&rdquo; of the Company, as such term is defined in Section&#8239;409A(a)(2)(B)(i)&#8239;of
the Code at the time of Executive&rsquo;s Separation from Service, then, solely to the extent necessary to avoid the incurrence of the
adverse personal tax consequences under Section&#8239;409A, the timing of the Severance Benefits will be delayed as follows: on the earlier
to occur of (i)&#8239;the date that is six months and one day after Executive&rsquo;s Separation from Service, and (ii)&#8239;the date of
Executive&rsquo;s death (such earlier date, the &ldquo;<B><I>Delayed Initial Payment Date</I></B>&rdquo;), the Company will (1)&#8239;pay
to Executive a lump sum amount equal to the sum of the Severance Benefits that Executive would otherwise have received through the Delayed
Initial Payment Date if the commencement of the payment of the Severance Benefits had not been delayed pursuant to this Section&#8239;6.8,
and (2)&#8239;commence paying the balance of the Severance Benefits in accordance with the applicable payment schedule set forth in Section&#8239;6.1.
No interest shall be due on any amounts deferred pursuant to this Section&#8239;6.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Parachute
Payments</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
any other provisions of this Agreement to the contrary, in the event that it shall be determined that any payment or distribution to
or for the benefit of Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or
otherwise (a &ldquo;<B><I>Payment</I></B>&rdquo;) would be nondeductible by the Company for Federal income tax purposes because of
Section&#8239;280G of the Code, the Company shall reduce the aggregate present value of the Payments under this Agreement to the
Reduced Amount (as defined below) if, and only if, reducing the Payments under this Agreement will provide Executive with a greater
net after-tax amount than would be the case if no such reduction was made, taking into account the applicable federal, state, local
and foreign income, employment and other taxes, including the excise tax imposed by Section&#8239;4999 of the Code. If a reduction in
the Payments is necessary, such reduction shall occur in the following order: (1)&#8239;reduction of cash payments;
(2)&#8239;cancellation of accelerated vesting of equity awards other than stock options; (3) cancellation of accelerated vesting of
stock options; and (4)&#8239;reduction of other benefits paid to Executive. Within any such category of payments and benefits (that
is, clauses (1), (2), (3)&#8239;or (4) of this Section&#8239;6.9(a)), a reduction shall occur first with respect to amounts that are
not &ldquo;deferred compensation&rdquo; within the meaning of Section&#8239;409A of the Code and then with respect to amounts that
are. The &ldquo;<B><I>Reduced Amount</I></B>&rdquo; shall be an amount expressed in present value that maximizes the aggregate
present value of Payments under this Agreement without causing any Payment to be nondeductible by the Company because of
Section&#8239;280G of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.75in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
determinations to be made under this Section&#8239;6.9 shall be made at the Company&rsquo;s expense by a firm of certified public accountants
of national standing selected by the Company (the &ldquo;<B><I>Accounting Firm</I></B>&rdquo;) which may be the firm regularly auditing
the financial statements of the Company. The Company and Executive shall furnish to the Accounting Firm such information and documents
as the Accounting Firm may reasonably require in order to make a determination under this Section. To the extent requested by Executive,
the Company shall cooperate with Executive in good faith in valuing, and the Accounting Firm shall value, services to be provided by Executive
(including refraining from performing services pursuant to a covenant not to compete) before, on or after the date of the transaction
which cause the application of Section&#8239;280G of the Code such that payments in respect of such services may be considered to be &ldquo;reasonable
compensation&rdquo; within the meaning of the regulations under Section&#8239;280G of the Code. In making its determinations hereunder,
the Accounting Firm shall apply reasonable, good faith interpretations regarding the applicability of Section&#8239;280G and Section&#8239;4999,
along with any other applicable portions of the Code or other tax laws. The Accounting Firm shall make all determinations required to
be made under this Section&#8239;and shall provide detailed supporting calculations to the Company and Executive within 30 days after the
Termination Date or such earlier time as is requested by the Company, and provide an opinion to Executive that he or she has substantial
authority not to report any excise tax on his or her Federal income tax return with respect to any Payments. Any such determination by
the Accounting Firm shall be binding upon the Company and Executive. Subject to Sections 6.1(c)&#8239;and 6.9, within five business days
thereafter, the Company shall pay to or distribute to or for the benefit of Executive such amounts as are then due to Executive under
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.75in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
a result of the uncertainty in the application of Section&#8239;280G of the </FONT>Code at the time of the initial determination by
the Accounting Firm or the Company hereunder, it is possible that Payments, as the case may be, will have been made by the Company
which should not have been made (&ldquo;<B><I>Overpayment</I></B>&rdquo;) or that additional Payments, as the case may be, which
will not have been made by the Company could have been made (&ldquo;<B><I>Underpayment</I></B>&rdquo;), in each case, consistent
with the calculations required to be made hereunder. In the event that the Accounting Firm, based upon the assertion of a deficiency
by the Internal Revenue Service against Executive which the Accounting Firm believes has a high probability of success determines
that an Overpayment has been made, promptly on notice and demand Executive shall repay to the Company any such Overpayment paid or
distributed by the Company to or for the benefit of Executive together with interest at the applicable Federal rate provided for in
Section&#8239;7872(f)(2)(A)&#8239;of the Code; provided, however, that no such amount shall be payable by Executive to the Company if
and to the extent such payment would not either reduce the amount on which Executive is subject to tax under Section&#8239;1 and
Section&#8239;4999 of the Code or generate a refund of such taxes. In the event that the Accounting Firm, based upon controlling
precedent or other substantial authority, determines that an Underpayment has occurred, any such Underpayment shall be promptly paid
by the Company to or for the benefit of Executive together with interest at the applicable federal rate provided for in
Section&#8239;7872(f)(2)(A)&#8239;of the Code.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>G</U></B></FONT><B><U>ENERAL
<FONT STYLE="font-size: 10pt">P</FONT>ROVISIONS</U></B><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Notices</U></B>.
Any notices required hereunder to be in writing shall be deemed </FONT>effectively given: (a)&#8239;upon personal delivery to the
Party to be notified, (b)&#8239;when sent by electronic mail or confirmed facsimile if sent during normal business hours of the
recipient, and if not, then on the next business day, (c)&#8239;five (5)&#8239;days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d)&#8239;one (1)&#8239;day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at its
primary office location and to Executive at Executive&rsquo;s address as listed on the Company payroll, or at such other address as
the Company or Executive may designate by ten (10)&#8239;days advance written notice to the other.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Severability</U></B>.
Whenever possible, each provision of this Agreement will be </FONT>interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any
applicable law or rule&#8239;in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision
or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provisions had never been contained herein.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Survival</U></B>.
Provisions of this Agreement which by their terms must survive the </FONT>termination of this Agreement in order to effectuate the
intent of the Parties will survive any such termination, whether by expiration of the term, termination of Executive&rsquo;s
employment, or otherwise, for such period as may be appropriate under the circumstances.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Waiver</U></B>.
If either Party should waive any breach of any provisions of this </FONT>Agreement, it shall not thereby be deemed to have waived
any preceding or succeeding breach of the same or any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #4471C4"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #4471C4">.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #4471C4"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #4471C4">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Complete
Agreement</U></B>. This Agreement constitutes the entire agreement between </FONT>Executive and the Company with regard to the
subject matter hereof. This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this
subject matter and supersedes any prior oral discussions or written communications and agreements. This Agreement is entered into
without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended
except in writing signed by Executive and an authorized officer of the Company, subject to the approval of the Board, its
compensation committee or (if necessary) the stockholders of the Company. The Parties have entered into a separate Confidential
Information Agreement and have entered or may enter into separate agreements related to equity. These separate agreements govern
other aspects of the relationship between the Parties, have or may have provisions that survive termination of Executive&rsquo;s
employment under this Agreement, may be amended or superseded by the Parties without regard to this Agreement and are enforceable
according to their terms without regard to the enforcement provision of this Agreement.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Headings</U></B>.
The headings of the sections hereof are inserted for convenience only </FONT>and shall not be deemed to constitute a part hereof nor
to affect the meaning thereof.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Successors
and Assigns</U></B>. The Company shall assign this Agreement and its </FONT>rights and obligations hereunder in whole, but not in
part, to any company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may
transfer all or substantially all of its assets, if in any such case said Company or other entity shall by operation of law or
expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally made a Party, but may not
otherwise assign this Agreement or its rights and obligations hereunder. Executive may not assign or transfer this Agreement or any
rights or obligations hereunder, other than to Executive&rsquo;s estate upon death.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Withholding</U></B>.
All amounts payable hereunder shall be subject to applicable tax </FONT>withholding.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Choice
of Law</U></B>. This Agreement in all respects shall be governed by and </FONT>interpreted in accordance with the laws of the State
of North Carolina, both procedural and substantive, without regard to conflicts of law, except to the extent that federal laws and
regulations preempt otherwise applicable law.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.10 <B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mandatory
Mediation</U>. </B>Prior to and as a condition of either Party&rsquo;s filing suit in state or federal court, the Parties shall engage
in a mediated settlement conference in accordance with the North Carolina Superior Court Rules&#8239;Implementing Statewide Mediation.
The Parties shall mediate in good faith until settlement is reached or an impasse is declared by the mediator.</P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Jurisdiction</U>.
</B>Each Party hereby irrevocably submits to the exclusive jurisdiction of the United States District Court located in Wake County, North
Carolina, or any state court located within such state, in respect of any claim relating to this Agreement or Executive&rsquo;s employment
with the Company, and hereby waives, and agrees not to assert, as a defense in any action, suit or proceeding in which any such claim
is made that said Party is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in such
courts or that the venue thereof may not be appropriate or that this Agreement may not be enforced in or by such courts. Any appellate
proceedings shall take place in the appropriate courts having appellate jurisdiction over the courts set forth in this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img01.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Counterparts</U></B>.
This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one Party, but all
of which taken together will constitute one and the same Agreement. Facsimile signatures and signatures transmitted by PDF shall be equivalent
to original signatures.</P>

<P STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURES TO FOLLOW ON NEXT PAGE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Liquidia</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have executed this Agreement on the day and year first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">L1QUIDIA TECHNOLOGIES,&#8239;INC.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Roger Jeffs&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name: Roger Jeffs</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Executive Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">EXECUTIVE:</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Rajeev Saggar</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Rajeev Saggar</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit&#8239;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Confidentiality,&#8239;Inventions
and Non-Competition</B></FONT><B> AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPRIETARY INFORMATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PROPRIETARY INFORMATION
AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is effective as of ________ (the &ldquo;<B>Effective Dat</B>e&rdquo;) by and between _______
(hereinafter &ldquo;<B>Employee</B>&rdquo;) and [Name of Employer] (together with Liquidia Corporation and all of its other subsidiaries,
collectively referred to herein as the &ldquo;<B>Company</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">STATEMENT OF PURPOSE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employee desires to be
employed by the Company, and the Company is willing to employ Employee strictly subject to Employee&rsquo;s agreement to be bound by the
terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN CONSIDERATION of the Company&rsquo;s
employment of the Employee and the compensation and other benefits that the Company may provide to Employee as an employee, the Employee,
intending to be legally bound, agrees to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. For purposes of this Agreement,
 &ldquo;<B>Proprietary Information</B>&rdquo; is information (whether in written or other form or whether or not patentable or protectable
by copyright, trade secret, trade dress, trademark, or the like) that: (i)&#8239;has been created, invented, discovered, or developed by
the Employee in connection with the Employee&rsquo;s employment by the Company; (ii)&#8239;is non-public and has been disclosed, furnished,
or communicated to the Employee in connection with the Employee&rsquo;s employment by the Company; or (iii)&#8239;is non-public and the
unauthorized disclosure of which could be detrimental to the interests of the Company. Proprietary Information includes, but is not limited
to, all inventions, works of authorship, trade secrets, know how, proprietary or confidential information, including, but not limited
to, research, product or business plans, products, services, projects, proposals, processes, formulas, ideas, data, compositions, technology,
computer programs and related source code and object code, developments, designs, drawings, marketing information and plans, customer
lists, budgets, projections, partners, cost analyses, acquisition candidates, relevant parts of analysis, reviews, compilations, studies
or other records and documents, and other information owned by the Company, disclosed to the Employee, or to which the Employee has been
provided access or gains access, either directly or indirectly, by any means. Proprietary Information does not include information that
is or becomes generally available to the public other than as a result of a disclosure by the Employee or by any other person or entity
that is under a confidentiality obligation to Company with respect to such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="" STYLE="height: 68px; width: 304px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. Nondisclosure of Proprietary
Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 The Employee acknowledges
and agrees that Proprietary Information is the sole property of the Company or its designee and that the Employee shall have no right,
title, license, or interest in or to any Proprietary Information. During and after the Employee&rsquo;s employment by the Company, the
Employee shall keep in the strictest confidence and trust all Proprietary Information and shall not directly or indirectly disclose, distribute,
copy, supply, or use, in whole or in part, any Proprietary Information except as approved in advance in writing by the Company. Notwithstanding
the foregoing, it is understood that, at all such times, the Employee is free (i)&#8239;to use information which was known to the Employee
prior to employment with the Company or which is generally known in the trade or industry through no breach of this Agreement or other
act or omission by the Employee, (ii)&#8239;to discuss the terms of the Employee&rsquo;s employment, wages and working conditions to the
extent expressly protected by applicable law, (iii)&#8239;to report possible violations of federal securities laws to the appropriate government
enforcing agency and make such other disclosures that are expressly protected under such laws, (iv)&#8239;to respond to inquiries from,
or otherwise cooperate with, any governmental or regulatory investigation, or (v)&#8239;to testify truthfully as compelled by lawful process
or subpoena related to such testimony after the Employee has provided advance written notice of said subpoena to the Company&rsquo;s Chief
Executive Officer and reasonably cooperates with the Company in any process to oppose said subpoena.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 The Employee shall not
use or disclose to the Company, or assist in the disclosure to the Company of, proprietary or confidential information belonging to any
third parties, including any prior employer(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 The Employee acknowledges
and agrees that the Company has received and in the future may receive from third parties, including, but not limited to, potential collaborating
partners or customers of the Company, confidential or proprietary information (&ldquo;<B>Third Party Information</B>&rdquo;) subject to
a duty on the Company&rsquo;s part to maintain the confidentiality of such information and to use it only for certain limited purposes.
During the term of the Employee&rsquo;s employment with the Company and thereafter, the Employee will hold Third Party Information in
the strictest confidence and will not disclose to anyone (other than Company personnel or the Company&rsquo;s designee who need to know
such information in connection with their work for the Company or such third party) or use Third Party Information, except in connection
with the Employee&rsquo;s work for the Company or such third party, unless expressly approved in advance in writing by the Company. The
Employee further agrees to be bound by and subject to any confidentiality or nondisclosure agreements or clauses with respect to such
Third Party Information between the Company and any such third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4 Pursuant to the Defend
Trade Secrets Act of 2016, the Employee acknowledges that the Employee will not have criminal or civil liability under any federal or
state trade secret law for the disclosure of a trade secret that (i)&#8239;is made (a)&#8239;in confidence to a federal, state, or local
government official, either directly or indirectly, or to an attorney and (b)&#8239;solely for the purpose of reporting or investigating
a suspected violation of law; or (ii)&#8239;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing
is made under seal. In addition, if the Employee files a lawsuit for retaliation by the Company for reporting a suspected violation of
law, the Employee may disclose the trade secret to the Employee&rsquo;s attorney and may use the trade secret information in the court
proceeding, if the Employee (x)&#8239;files any document containing the trade secret under seal and (y)&#8239;does not disclose the trade
secret, except pursuant to court order.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. Upon the earliest to occur
of (i)&#8239;termination of the Employee&rsquo;s employment by the Company for any reason, (ii)&#8239;termination of the Employee&rsquo;s
access to Proprietary Information, or (iii)&#8239;the request of the Company, the Employee shall return to the Company (and will not keep
in Employee&rsquo;s possession or control or deliver to anyone else) all materials belonging to the Company, whether kept at the Employee&rsquo;s
business office, personal residence or otherwise, including, but not limited to, all materials containing or relating to any Proprietary
Information in any written, tangible, electronic or other form that the Employee may have in Employee&rsquo;s possession or control, and
any and all mobile telephones, personal digital assistants, pagers, computer and other electronic devices and credit cards. After returning
the materials and equipment described in the preceding sentence to the Company, the Employee shall not retain any copies of any such materials.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. Ownership of Proprietary
Information.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 All Proprietary Information
and other information, which by its nature is proprietary to the Company, relating to the Company&rsquo;s business or the Company&rsquo;s
anticipated business, or based on, derived from or relating to any Proprietary Information (collectively, Proprietary Information and
 &ldquo;<B>Work Product</B>&rdquo;) shall be the sole property of the Company. The Employee agrees that all Proprietary Information and
Work Product created, conceived, reduced to practice, made or otherwise developed by the Employee, solely or jointly, during and in any
way related to the Employee&rsquo;s employment, shall be the exclusive property of the Company and/or its designees or assignees, and
shall be deemed &ldquo;works made for hire,&rdquo; as that term is defined in Section&#8239;101 of the U.S. Copyright Act of 1976, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 If, for any reason, any
Proprietary Information and Work Product does not qualify as works made for hire, the Employee shall assign and does hereby irrevocably,
unconditionally, and without encumbrance of any kind assign to the Company, and forever waives and agrees never to assert, all right,
title, and interest, including without limitation, all patent, trademark, copyright, trade secret, and other intellectual property (collectively,
 &ldquo;<B>Intellectual Property</B>&rdquo;) rights, in and to such Proprietary Information and Work Product. The Employee shall assist
the Company, or its designee, in every proper way to secure the Company's rights in the Proprietary Information and Work Product and any
Intellectual Property rights relating thereto in any and all countries, including (i)&#8239;the disclosure to the Company of all pertinent
information and data with respect thereto, (ii)&#8239;the execution of all applications, specifications, oaths, assignments and all other
instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the
Company or its designee the sole and exclusive right, title and interest in and to the Proprietary Information and Work Product, and (iii)&#8239;the
defense of any claim, demand, action, litigation, suit, or other proceeding, including, but not limited to, interference, cancellation,
opposition, or other proceedings in respect of such applications or any registrations or patents issuing therefrom. The Employee shall
continue such assistance after the termination of the Employee&rsquo;s employment by the Company.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 During the Employee&rsquo;s
employment by the Company, the Employee shall report promptly to the Company all Proprietary Information and Work Product created, conceived,
reduced to practice, or otherwise developed by the Employee, solely or jointly.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 If the Company is unable
because of the Employee&rsquo;s mental or physical incapacity or for any other reason to secure the Employee&rsquo;s signature to apply
for or to secure protection of any Proprietary Information and Work Product, then the Employee hereby designates and appoints the Company
and its duly authorized officers and agents as its agents and attorneys-in-fact to execute and file any certificates, applications or
documents and to do all of their lawful acts necessary to perfect and protect the Company&rsquo;s rights in the Proprietary Information
and Work Product. The Employee expressly acknowledges that the foregoing power of attorney is coupled with an interest and is therefore
irrevocable and shall survive the Employee&rsquo;s death or incompetency and the termination of the Employee&rsquo;s employment or engagement
by the Company.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 The Employee hereby represents
and warrants that the Employee has fully disclosed to the Company on Schedule A attached hereto any idea, invention, discovery or process
relating to the Company&rsquo;s business which, prior to the Employee&rsquo;s employment with the Company, the Employee conceived, reduced
to practice, or developed, individually or jointly, and is to be excluded from the scope of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 Notwithstanding anything
in this Agreement to the contrary, the obligation of the Employee to assign or offer to assign the Employee&rsquo;s rights in an invention
to the Company shall not extend or apply to an invention that the undersigned developed (i)&#8239;entirely on the Employee&rsquo;s own
time; (ii)&#8239;without using Company equipment, supplies, facilities, or other resources, Proprietary Information or trade secret information
unless such invention (a)&#8239;relates to the Company&rsquo;s business or actual or demonstrably anticipated research or development,
or (b)&#8239;results from any work performed by the Employee for the Company. The Employee shall bear the burden of proof in establishing
that the Employee&rsquo;s invention qualifies for exclusion under this Section&#8239;4.6.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. Covenant Not To Compete.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 For purposes of Part&#8239;5
of this Agreement, including each of its subparts, the following terms shall have the following meanings:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a. &ldquo;<B>Competing Business</B>&rdquo;
shall mean any corporation, partnership, person, or other entity that is researching, developing, manufacturing, marketing, distributing,
or selling any product, service, or technology that is competitive with any part of the Company&rsquo;s Business.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b. The &ldquo;<B>Company&rsquo;s
Business</B>&rdquo; shall mean the development, manufacture, marketing, distribution, or sale of, including research directed to, any
product, service, or technology that the Company is developing, manufacturing, marketing, distributing, or selling or to which the Company
directed research at any time during Employee&rsquo;s employment with the Company. As of the date of this Agreement, the Company&rsquo;s
Business includes, but is not limited to, research directed to and the development, manufacture, marketing, distribution, and/or sale
of: (i)&#8239;isolated size and/or shape controlled pharmaceutical or therapeutic particles fabricated from a mold, including products
of or containing the isolated size and/or shape controlled pharmaceutical or therapeutic particles fabricated from a mold; (ii)&#8239;size
and/or shape controllable pharmaceutical or therapeutic particles molded using a polymer or low surface energy mold; (iii)&#8239;film based
products of or containing arrays of size and/or shape controlled structures molded from a low surface energy mold; (iv)&#8239;isolated
nano or micro size and/or shape controlled particles fabricated from a mold, including products of or containing the isolated size and/or
shape controlled particles fabricated from a mold; (v)&#8239;nano or micro size and/or shape controllable particles molded using a polymer
or low surface energy mold; or (vi)&#8239;patterned drum fabrication and mold for manufacturing the products of (i)-(v)&#8239;above. The
Employee understands that during the Employee&rsquo;s employment with the Company, the Company&rsquo;s Business may expand or change,
and the Employee agrees that any such expansions or changes shall expand or contract the definition of the Company&rsquo;s Business and
the Employee&rsquo;s obligations under this Agreement accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c. &ldquo;<B>Territory</B>&rdquo;
shall mean the following severable geographic areas: (i)&#8239;the world, (ii)&#8239;any country in which the Company or a Competing Business
is engaged in business, (iii)&#8239;any country in which the Company is engaged in business, (iv)&#8239;the United States, Europe, and Asia,
(v)&#8239;the United States, (vi)&#8239;any state, including the District of Columbia, in which the Company or a Competing Business is engaged
in business, (vii)&#8239;any state, including the District of Columbia, in which the Company is engaged in business, (viii)&#8239;North
Carolina, (ix)&#8239;a one hundred mile radius of the Employee&rsquo;s principal place of employment or work for the Company, or (x)&#8239;a
one hundred mile radius of the Company&rsquo;s corporate headquarters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 It is recognized and understood
by the Employee that, through the Employee&rsquo;s association with the Company, the Employee shall: (i)&#8239;have access to trade secrets
and confidential information of the Company, including, but not limited to, valuable information about its intellectual property, business
operations and methods, and the persons with which it does business in various locations throughout the world, that is not generally known
to or readily ascertainable by the Company&rsquo;s competitors, (ii)&#8239;develop relationships with the Company&rsquo;s customers and
others with which the Company does business, and these relationships are among the Company&rsquo;s most important assets, (iii)&#8239;receive
specialized knowledge of and specialized training in the Company&rsquo;s Business, and (iv)&#8239;gain such knowledge of the Company&rsquo;s
Business that, during the course of the Employee&rsquo;s employment with the Company and for a period of one year following the termination
thereof, the Employee could not perform services for a Competing Business without inevitably disclosing the Company&rsquo;s trade secrets
and Proprietary Information to that Competing Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 While employed by the
Company, the Employee will not, without the express written consent of an authorized representative of the Company: (i)&#8239;perform services
(as an employee, independent contractor, officer, director, or otherwise) for any Competing Business, (ii)&#8239;engage in any activities
(or assist others to engage in any activities) that compete with the Company&rsquo;s Business, (iii)&#8239;own or beneficially own an equity
interest in a Competing Business, (iv)&#8239;request, induce, or solicit (or assist others to request, induce, or solicit) any existing
or prospective customers, suppliers, business partners, or contractors of the Company to curtail or cancel their business with the Company
or to do business within the scope of the Company&rsquo;s Business with a Competing Business, or (v)&#8239;request, induce, or solicit
(or assist others to request, induce, or solicit) any employee of the Company to terminate his or her employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 For a period of one year
following the termination of the Employee&rsquo;s employment with the Company, the Employee will not, without the express written consent
of an authorized representative of the Company: (i)&#8239;perform services (as an employee, independent contractor, officer, director,
or otherwise), within the Territory for any Competing Business, that are the same or substantially similar to any services that the Employee
performed for the Company or that otherwise utilize skills, knowledge, and/or business contacts and/or relationships that the Employee
developed while providing services to the Company, (ii)&#8239;engage in any activities (or assist others to engage in any activities) within
the Territory that compete with the Company&rsquo;s Business, (iii)&#8239;own or beneficially own an equity interest in a Competing Business,
(iv)&#8239;request, induce, or solicit (or assist others to request, induce, or solicit) any existing customer or any prospective customers
to whom the Company has made a written proposal (&ldquo;<B>Prospective Customers</B>&rdquo;), suppliers, business partners, or contractors
of the Company, during the last year of the Employee&rsquo;s employment with the Company, to curtail or cancel their business with the
Company or to do business within the scope of the Company&rsquo;s Business with a Competing Business, (v)&#8239;request, induce, or solicit
(or assist others to request, induce, or solicit) any existing customer or Prospective Customers, suppliers, business partners, or contractors
of the Company with which the Employee worked or had business contact during the last year of the Employee&rsquo;s employment with the
Company to curtail or cancel their business with the Company or to do business within the scope of the Company&rsquo;s Business with a
Competing Business, or (vi)&#8239;request, induce, or solicit (or assist others to request, induce, or solicit) any employee of the Company
to terminate his or her employment with the Company. Where a Competing Business is a large enterprise with separately operated business
units, the restrictions in Section&#8239;5.4(i)&#8239;shall not apply to any such business unit that has no involvement in the research,
development, manufacture, marketing, distribution, or sale of a product, service, or technology that is competitive with any part of the
Company&rsquo;s Business; <I>provided, however</I>, that this sentence does not apply to any employees in a scientific role or whose role
involves the research, development or maintenance of the Company&rsquo;s trade secrets. These obligations will continue for the specified
period regardless of whether the termination of the Employee&rsquo;s employment was voluntary or involuntary or with or without cause,
and the specified period shall be tolled and shall not run during any time in which the Employee fails to abide by this obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 The Employee shall not
at any time following the termination of the Employee&rsquo;s employment with the Company use the name or trading style of the Company
in any country, or use in any country any name or trading style which is the same as or similar to any of the trade or service marks of
the Company or any brand name or proposed brand name of any of the Company's products or proposed products, or represent himself or herself
as carrying on or continuing or being connected with the Company or its business for any purpose whatsoever unless otherwise agreed by
the Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 While employed by the
Company, the Employee shall disclose to the audit committee of the Company the Employee&rsquo;s interest in respect of any contract or
arrangement in which the Employee has any personal material interest, directly or indirectly, or any conflicts of interest (including
the conflict of interest that may arise from the Employee&rsquo;s directorship(s)&#8239;or executive position or personal investments in
any corporation(s)) that may involve the Employee. Upon such disclosure, the Employee shall abstain from voting in respect of any such
contract, arrangement, proposal, transaction, or matter in which the conflict of interest arises, unless and until the audit committee
has determined that no such conflict of interest exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 As an exception to the
restrictions set forth in Parts 5.3 and 5.4 herein, the Employee may own passive investments in a Competing Businesses, (including, but
not limited to, indirect investments through mutual funds), provided that the securities of the Competing Business are publicly traded
and the Employee does not own or control more than two percent of the outstanding voting rights or equity of the Competing Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 In the event that a court
determines that the length of time, the geographic area, or the activities prohibited under this Agreement are too restrictive to be enforceable,
the Court may reduce the scope of the restriction to the extent necessary to make the restriction enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 The market for the Company&rsquo;s
services and the Company&rsquo;s Business is highly specialized and highly competitive such that other companies and business entities
compete with the Company in various locations throughout the world. The provisions set forth in this Agreement: (i)&#8239;are reasonably
necessary to protect the Company&rsquo;s legitimate business interests, (ii)&#8239;are reasonable as to the time, territory, and scope
of activities that are restricted, (iii)&#8239;do not interfere with the Employee&rsquo;s ability to earn a comparable living or secure
employment in the field of the Employee&rsquo;s choice, (iv)&#8239;do not interfere and are not inconsistent with public policy or the
public interest, and (v)&#8239;are described with sufficient accuracy and definiteness to enable the Employee to understand the scope of
the restrictions on the Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 Because of the unique
nature of the Proprietary Information, the Employee understands and agrees that the Company will suffer irreparable harm in the event
that the Employee fails to comply with any of the Employee&rsquo;s obligations under this Agreement and that monetary damages will be
inadequate to compensate the Company for such breach. Accordingly, the Employee agrees that the Company will, in addition to any other
remedies available to it at law or in equity, be entitled to injunctive relief to enforce the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. The Employee hereby authorizes
the Company to provide a copy of this Agreement, including any exhibits hereto, to any and all of the Employee&rsquo;s future employers
and to notify any and all such future employers that the Company intends to exercise its legal rights arising out of or in connection
with this Agreement and/or any breach or any inducement of a breach hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. The Employee agrees that,
during the term of the Employee&rsquo;s employment with the Company, the Employee will not: (i)&#8239;engage in any other employment, occupation,
consulting, or other business activity that conflicts with the Employee&rsquo;s obligations to the Company, or (ii)&#8239;engage in any
other activities that conflict with the Employee&rsquo;s obligations to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8. Debarment Certification</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8.1 The Employee represents and promises that Employee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&#8239;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">is not presently, and during the Employee&rsquo;s employment will not be, debarred or convicted for a crime for which Employee can be debarred under the Generic Drug Enforcement Act of 1992 (21USC335a)(the &ldquo;<B>Act</B>&rdquo;); and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&#8239;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">is not presently, and during the Employee&rsquo;s employment will not be, indicted or otherwise criminally or civilly charged by a government entity (Federal or State) with commission of the kinds of conduct for which Employee can be debarred under the Act; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&#8239;</TD>
    <TD STYLE="width: 24px; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">will not employ or otherwise engage any individual who has been (i)&#8239;debarred or (ii)&#8239;convicted of a crime for which a person can be debarred under the Act, in any capacity in connection with the activities of developing or reporting data which may become part of an application for approval of a drug or biologic.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2 The Employee promises
that, during the Employee&rsquo;s employment with the Company, the Employee will promptly notify the Company upon learning of or having
a belief that the Employee cannot satisfy the obligations of Section&#8239;8.1 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. The Employee agrees that
this Agreement shall be enforced, construed and interpreted under the law of the state of North Carolina, without regard to the conflicts
of laws principles thereof. The state and federal courts in North Carolina shall be the exclusive venues for the adjudication of all disputes
arising out of this Agreement, and the Employee consents to the exercise of personal jurisdiction over the Employee in any such adjudication
and hereby waives any and all objections and defenses to the exercise of such personal jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. The Employee agrees that:
(i)&#8239;the Employee&rsquo;s employment relationship with the Company is &ldquo;at-will,&rdquo; which means that either the Employee
or the Company can terminate the relationship at any time for any reason or no reason, with or without notice, unless the Employee and
the Company are parties to a contract that expressly provides a fixed term of employment, (ii)&#8239;the Employee&rsquo;s employment relationship
with the Company is contingent upon the Employee&rsquo;s execution of this Agreement, which is a material inducement to the Company to
offer the employment relationship to the Employee and to provide Proprietary Information to the Employee, and (iii)&#8239;this Agreement
shall survive any termination for any reason whatsoever of the Employee&rsquo;s employment relationship with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. The Employee agrees that
the Company&rsquo;s failure to insist upon strict compliance with any provision of this Agreement shall not be deemed a waiver of such
provision or of any other provision in the Agreement. The provisions of this Agreement shall be enforceable, notwithstanding the existence
of any breach of this Agreement by the Company or of any claim by the Employee against the Company, whether predicated on this Agreement
or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12. This Agreement contains
the entire understanding between the parties with respect to the subject matter hereof and supersedes all prior or contemporary agreements
or understandings, whether written or oral, with respect thereto, provided, however, prior to the execution of this Agreement, if Company
and the Employee were parties to any agreement regarding the subject matter hereof, that agreement will be superseded by this Agreement
prospectively only. This Agreement may not be modified or amended except by an agreement in writing signed by both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13. The Employee agrees that
this Agreement is assignable by the Company at the Company&rsquo;s discretion and the Employee authorizes the Company&rsquo;s successors
and assigns to enforce this Agreement for their respective benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. The invalidity or unenforceability
of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement and each other
provision of this Agreement shall be severable and enforceable to the extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15. The Employee agrees that
a breach of any provision(s)&#8239;of this Agreement will toll the running of the limitation period with respect to such provision(s)&#8239;for
as long as such breach occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16. The Employee agrees and
acknowledges that the Company&rsquo;s agreement to employ the Employee, in and of itself, is sufficient and adequate consideration for
the Employee&rsquo;s promises and obligations hereunder, and that the compensation and other benefits that the Company provides the Employee
during the course of the Employee&rsquo;s employment are, independently and collectively, sufficient and adequate consideration for the
Employee&rsquo;s promises and obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, and intending
to be legally bound hereby, the Employee has executed this Agreement to be effective as of the date set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">[NAME OF EMPLOYER]</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"> (s)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> (s)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2219020d1_ex10-1img02.jpg" ALT="">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following items are inventions,
ideas, computer software programs or other equipment or technology not covered by Section&#8239;4 of this Agreement, which the undersigned
conceived of or developed, wholly or in part, prior to the Employee&rsquo;s employment or engagement with the Company and shall be excluded
from the scope of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>If the undersigned has
no such items to disclose, write &ldquo;NONE&rdquo; on this line: _____________.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Description of Items: (if applicable)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="background-color: White; vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center; width: 32%; font-size: 10pt">Title on Document</TD>
    <TD STYLE="background-color: White; text-align: center; vertical-align: bottom; width: 2%">&#8239;</TD>
    <TD STYLE="background-color: White; vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center; width: 32%; font-size: 10pt">Date on Document</TD>
    <TD STYLE="background-color: White; text-align: center; vertical-align: bottom; width: 2%">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; font-size: 10pt; text-align: center">Name of Witness<BR>
on Document</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD>
    <TD STYLE="background-color: White">&#8239;</TD>
    <TD STYLE="background-color: White; border-bottom: black 1pt solid">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>[NAME OF EMPLOYER]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 46%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Name Dated:</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&#8239;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lqda-20220615.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaeEqbOdzZR+WYkxtmBxbUmqjy4oa/AMSSHZdd1G8S4M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:lqda="http://liquidia.com/20220615" elementFormDefault="qualified" targetNamespace="http://liquidia.com/20220615">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://liquidia.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="lqda-20220615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lqda-20220615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lqda-20220615_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lqda-20220615_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://liquidia.com/role/Cover" xlink:href="lqda-20220615.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://liquidia.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2219020d1_ex10-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2219020d1_ex10-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  M +<# 2(  A$! Q$!_\0
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:.>>73K80O/\ ZP@DYYS16K12;;U8TDMC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2219020d1_ex10-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2219020d1_ex10-1img02.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !$ 3 # 2(  A$! Q$!_\0
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M3/#GP]T619&M'UNZ\F^U611E(-*TJ*.;5M2GF("PQV-E,\I("[CQ7Y&^)?\
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MG.0Z(0$=F#22&),JJDA3(&7>1L&UF+!5)#Y&95)49(^G;KU(^G>OY^_VXO\
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M_P CI6K2Z-ZBM+&HW,ZJN0NYB%7<2 %R<#<20 N<D\ 4[>N >>?4,#WY((R
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M?C#-KWB YE_T_P -_"?P\VKW>FLL09I;>ZUW6_#EQ-"1ESI2A(Y/-0G\>?\
M@V,N]1T[_@H5XTTJ"ZN;2TG_ &:?B M_IEM=S&SU*XL/&_PQEAN-3*RI92+I
M,+FVL%BTN>Y$=W@ZA/MFEK[&MX79?Q)X;XKB7-95IRH8VI2IT82I?5K**@^:
M,J<JJE)Z<RJ65K<C3T]3P\^D#Q_X)^*V6X[P]S/^R<TJX*K2EBJ6#PN-G4I.
M$JLZ&(I8VEB*$J#NVE"E3J.;?[QQ]T_7;P]^R-^P#_P2B\.:7\3/VN?%=M\=
M?CY-8IJ?ASPG+H]O<V-O?62KY#>"?AQJ3:AI\$%G.IBD\9?$FYO;821"?2)[
M"1X[=?S&_;$_X*U?M)_M:7 ^'WP_34_A'\*-8+Z;I/P_\%K=-XJ\>V"NT=M#
MXD\1V%PFHZC#':F//ASPQ:6NFV+%K6/4]3MHHY9/U$U[_@IA^Q)^V!^T3\5O
MV OVXO@W:>&_%7A?X_\ C7X-?!SXDV-KJ6N:?K6IV'Q U#P-X->'Q'I]B?'7
MPR\9WRPZ='<:II0U#1KN[N9KMM?\/Z*'TY?UU_9!_P""=/[.W[&>AW\GPS\.
MCQ!XQUV]N;S5?B5XSET[5O&E]IDLS2Z9HD>N-9R0V.E:7;NEO:)H]C9?:(XH
MY;@HY"I^)<0>'W%V4/!</X2IA<FR/&4%B)*G1E"OBZ-6"2A4JWY9T[2]K'EC
M%J=U)M)(_M+PT^EGX2XO#YQXH^*7"W$/C5XZ8?-L10RN/&.>87"\$<.82,I5
M52R_A^EA:639;2G62H3Q']G5\>XPA*EBHR3E#^&7P1XA_:B_9-\4:7\4_"4'
MQ7^"^N6<]K+;>(]1\/>(O#NFZY991X[&YM]6L+*P\6V-S'M$]KK2".*-C]DU
M2Z&V=_WD^#?_  58_9<_;1\':=\ ?^"C?PV\)VE_<JMCI_Q7TG3+B3PE#J4\
M26=KK4MQIJWWBKX3Z^TGS2:OH>I:AHS74LP?6_#^FG^RX_Z@]<\':%XRT:[\
M/^*O#^G^(M"O[>YMM0TS5!INJPW<5TCQ2PR6MY:21"#9(Q9H;F!^ =I(51^/
M'B#_ ()M?\$\_P!D[QYXD_:1\:^"+W7;:_UY)_!'P\URW/B?P5X9\3%;R_.E
M^%_#3VUQ8C^VKR&XU2RG\9OK&E:!% EII3>'PEO;'R,)X?<8X+$87*LFS;^U
M<#C,5A\/6RK&Q]OAJ<*U5*M4H4Z?LZOM9P;IIRJN*]UN-KR7UO&/TP/!#Q4R
M#,\Z\4O#/%<!<><.X&6+\/>+O#CB98?'Y7C,)>6%P$<^H4*&,JY?AN2EB'EV
M82QV%_B.GO[.7YT>.?\ @WXO?$_C_P +:W\ ?CSX3U+]GGQ-:66K)XB\413:
MUXI\(^'IH8KR$>'9_"LB>'_&=IJ6F30'3-3BU/POY,#PW6J77B9G=YOVY_9!
M\-_LV_LB:7X6_8_^%WQ \0>,?$$4/B'6YEUC59=<E.L6\#ZGK[75S96T6E:+
MYVR>YM=&T!8H(!YEK]BMC (%TM%^/M[\=?V8OVBO&VG:,/"ECX9T_P ::)X8
MM%N?M$\>GZ=X*L;V*XNH;>.SMX99ENC(+>"5X[=I#&CG:2WXK_"3Q.WP_P#B
M5X \7V\K)_PCOB_0M1U"?R@ERVF6ES&NJ0/+')//-%>:9=7XDB#SR2+;^61)
M))&)/WG@CP?PE"7%&+HX6&78S 2^I5X85PA"I*G3>*5.LVI;5>92]GRIIWO[
MJO\ P/XY?3-\7?$/ <%<,<6\3XG/.'U'Z_@JV-P&!H8G$UIPCE<<RQ57 X;#
M0KYC4R^G1HU,1*FE**=3V;JSG4E_5JLN57Y<G8#(F"I7(R.N.<C.!D@\5(K*
M0F!U' ]@!Q[8Y%5K,-)%$[\-)"@8Y!.X#G)R<\\9YY[5.!C8/3</RXKY1RE)
MU*7-R2IU:T>:G:[C2BI1^+F7O;2=KN+LN5ZGCT)*K["I'6$\'&I[1Z5)2E&,
MFI-6C97<K)+WM;VT/\UO_@O@,?\ !6G]K'W?X''_ +Z_9Z^"I_K^%?WD?\$U
MO^4?'[%'_9L_P5_]0G0:_@X_X+X_\I:?VL/K\#/_ %GCX*5_>/\ \$UO^4?'
M[%'_ &;/\%?_ %"=!K]LX^YUX>>&Z=2<U6HXBNU+EM"4<###J,+134/9Q6DG
M)WUO;0_+N#)O_6CBA66T%?6_^_U?,^Y58!5R?X5]?2HRN-S;3DMD<Y# GJ?[
MN?S]J#T3_<7^5 .#UP?_ -?;_P"L?7M7XC5G3BDJDX0YI)1]I>SEH[*S2OUU
M=OF?JJOJTWHM8JS4EV>C>F^EF?BS_P %*?\ @CG\./\ @I#\1_ GQ&\9?&?Q
MK\*[_P"'O@_5/!UII_A?P[HNJVVIV>HZN^O&]NKG5KV*5'@N)VC)@3:#D!E(
MP/L_]A/]DKPY^P[^S7X(_9M\(^,M9\>Z#X*U?QKJ&G>*M?AL["^N7\8>(_$7
MBFY@M[33Y)+9SIU[J<]JL3N[Q1I(Y8%<#^6C_@Z"\=^/?!_[2_[.=EX3\<>+
M_"UG?_!G6KF^M/#?BOQ!X:MKJ2X\=WMF]]<0:+=1Q7DMK;1QP[KA!-(#\B,H
M)K]P_P#@@1K^N^)_^"8/P1U?Q1JVL:_JMQXE^,;W>K:SJUYKFH7BCXJ>-;.#
M=?ZD[WL:V-K#%:QQAVV1P[(@R,6/Z1F^7Y[0X%R;,\9FTL3D,L966%P"Y4L'
M7EA9*56*U?-.$72=W+37>Y\'EU?)Y\4YCAL)@*&%S>IAZ:J5Z49Q>(A#$.;C
M63FTU&5ZBY.5N;>K6A^T[7ENBEGE4(JN[._R!4B7,LDA(58TB.!*[!4C;*L5
M;Y0XW5N@8/,BF, N&.TJ.1D@@'L>G]17\]G_  6L_P""PMU^PAI6D_!+X%QZ
M;J?[37CC1WUE-7UNVCOM ^$GA2\N+S3K7Q/J>GLKQZIXCU1K>8>&O#MWN@N;
M58=7U&***YMI)/Y$_!G@3_@I_P#\%/O$^O:WX7_X7Y^T3>VEVPU35]>\6SZ+
MX!T*YGDDG>V;Q!XI\9^%_!/AD%RZV6A6EQ)';(JV5A%+%%&M/ASPXQ^<94\Z
MQN8X'),K:YZ5;&ODG7@W;]W&4X*32]Z]_>33C%*W-IG/&^"RW'_V5A,%C,TS
M/6G*GA4I4Z516?[SEC)J-_=T:?,FKZ'^GU_:=AY<DOVF,1P_ZYCN B!SM:7(
M!C23&8G8!95PT9=2"9#>VBIYK3QK& "S,<!<JK@/D#8Q5U.U\-AAQS7^;+!I
M7_!87_@D3XC\-?$/6],^,OPH\)Q:O: VMWXGM_B)\'M<@EDW7OA_Q2NG:EXZ
M\%V\^IP!OL$=_%X<UZPMGCFM;E0$DKY/\7_M>_&7XZ?M8ZA\7[CQKX\\'CXF
M_&K3/&LW@S2O'_C6#0O#UQXC\<V^HWNAV>D2Z@T)TZU%_)806]TQD6VA2.<E
MPV?7H>$F/QCJXS Y[E6,RFG0J5/;4)*5>,Z2<I>TBJLHJG.*:A)*RE=2;=D_
M)Q/B13P2IX7&Y)F.&S*56E&5.<+4)0JSC%.FW'GYU>[3DU:S75'^J5]MM1NS
M+C;O+Y20;!'OWL^4&U1Y;C<V%)  )+*"JWEL[!%F4NV"J88.P)QN"$!BO!RP
M&T $DX!-?GI_P5$N-3TK_@G9^V/J>E7UUIFI:=^SQ\0[FPU"TDD2^T^\M] N
MKFUO[>^AN[6]MY4D80J8)]Z *RL5R3_'I_P;O_$SXD^)_P#@I+X3T?Q-X]\;
M^)-'G^%?Q/NY-)UOQ1K>HZ?]MTW2('L9/L^H:Q?1OY3RR>673@@,]?'93PGB
M\TX?SO/*>*HRCD]5QJ4H0>M-M*$YMU'RM/22UNTTK)-GT69\44L!F^6Y:\-4
MC',,-2K1G5OS>TJ25Z<>6R?+!IZJ]_DC_0<$B, RL"K ,I&2"K $$'T(((JN
MU_9HVQ[B-&WM&%<E69T\L.J!@#(5,L8;9N +@$YXI8P1'&NXL5CC!8G);:@!
M8D@9)P23@$GL.E?RB_\ !TIXQ\8^#?AE^R?-X/\ %?B7PK+J_C3XK6U_-X<U
MO4=)>]2P\/\ A:^L89_L%Y8L^V=W(9I,+W;/S'S^&\FJ\19_E>0TZ]/#ULRG
M5IPJ3C>*G3I.HK)R5E>+O=O1JVNIZV=9I'*,LQ68.C.LZ-.$X0CWE-*\^KCR
MO2S3OUZ']71N(65E$@SDCD,HR<N%RP W;!NVYR%(8C!!/\^W[<G_  04^$7[
M<7[2OCK]I+Q+\>OB)X#UOQS:^$;34?#GAKPUH&H:= G@WPCIGA2W5[S4KN.Y
M#7]I:PW#(J1</DG:"P\J_P"#8OQ'XH\7?L=?&S4/$_B+7?$VH0?M+:S;P:IK
MNI7^K7\-BGPK^&<26<=YJVIZA<Q)'-=W-\4A,<0>YE5?,=V4?@3_ ,%[OBA\
M3?#'_!47X_:/X9^(GC?0='L-)^#DUEI.C>+/$FC6%M<GX2^ +^0FTTS5H+2X
M;5;J:2ZFDDBC'F,3<;7)S]IPUPKQ'A.,\SX=R_.Z.7YE@Z6+CB*V&2Y:N"I^
MSE[.?-*3E>?+)\G*FU9VY;/Y+.L_RW$\/X+'YE@)>PQ-:"BJWPPJN*LX6L[Z
MV?-=<NF^I_?=\"/A3IOP)^"/PH^"^D:G=Z_I?PH^&WA'X>Z?K=\D<-[JEIX-
MT#3O#MMJ-W#$SQ175[%IT=U<Q0NT:32R(CE0&KV;[3;Q)AG,:QLD):1)%4,4
M4J-Y0(P(95WJ2AD/E;O,R@^/OV!M1N;_ /89_9)U'5K^XU'4;[]FCX-7E_J%
MY+-<75Q-/\./#TDEW=SS/-,\MPR23RS3R/)(\A9Y'D;+?RD?\%=_^"\?Q7N_
MBCXU_9T_8P\82_#OP)X!U35_#GCOX[>&FT[_ (3+Q?J]K?7=AKUEX#\1:E#=
MCP9I.C7-M) /$.CZI8:UKVF*FI:)J6C:7*MM7RV4\+YMQ+Q!FF!P6(PU6>&Q
MU:GC<;64XTZ;C6E3E.K-3Y5S5%)QC%<SUOM<]_%9WE>2Y9@JE6-.A7Q&%@\%
MAZ:=Z\>2,XQ2;;=DTVUNW\C^WAKVU2,RO,L<:[,M(&CP7("@APIR20",9!R#
MC!Q^?'_!526$_P#!.7]M8ET3S?V>_B1!&96$*O+)H-Q%&H:4H,R.,)D@-D$9
M4AC_  5?##_@G+_P5=_:VT:'XR^%/A'\:?&VFW_^GZ5XR\>?$33/">M7Y*_:
MXM0\/R_%#QEX>\3S65VCK<V%[I""TNX)(Y;*5XW0GHM>_:V_X*2_L4>!OC-^
MQK^TQ;_$J7P)\7OA-XZ\":C\._C:UUJBZ;IOB:SN]&O?%WPK\>RMKL46E:"&
MM)O$.J6UUX@\+WUS-.=7M7U-+K4H?T7#>%<L/G&6X?!\89#BL=0QF'K8K"4*
ML?:TZ<*E*45=SJ6G[12CR\MW)1B^6]SY7$<<RJ8#%4\9DV.P4*M&K".)J0DJ
M-5.,K>Q;BGSQ5IMMM<KVN>V?\&X?'_!3CP2&!!'PJ^+3%64JP_XDEK@,I (.
M[ *D @Y! P<?V&_\%+/^";/@3_@I%X'^''@GQU\3/$OPSL_ASXNO/%NF:CX9
MT;3M2N+^_P!5LO[-GMR+^ZC4-%;QC("G<6W8&X@?QZ?\&X(*_P#!3SP3N(R/
MA1\6TR8G@!?^Q+4?ZF2:YDARW_+-[B=H_N-/*P,C?MA_P=">+?%OA+X#?LQ7
M7A3Q+XC\*76H?&#Q+8WUYX?U_5=*EO;*W\)Q:C##/_9MY8NR1WC%41G)0#.X
MJ1MZN/L+FN8>,G#^683$U,LS6&64<-A,<E&-&-2C1DU6H.UO:227,Y<\73O9
M)NZX>&\1@J/ N98ZK1CB\.\95?)B;SB^:234N3D=DGIJM;=M?UK_ .":W_!.
M7P7_ ,$W_AQ\0OA[X/\ B7XK^)]CX^\:0^-;O4O&.G:9I%SI]Q:^'[+0!96T
M&F-+ \<L%E'(6E8$C)R2,G],A<P+&&:545<(6<@*''&PO@)OSQ@'D\ 5_+U_
MP:^^+?%OBO\ 9>_:.U+Q-XBU[Q5JEM\<[2ULYO$>J7^KW%M GP^T&:&TAOM5
MU34)H8KF[N6F98R(D+,' SE?(/\ @O7^U_\ \%)OA)\>_AW\!_V>=4\3>#?A
M%\6/#BR^"M7^#&A:E=_%/XB^)-'U"W7Q[X5O?$6GZ/KWBFTMO#=MJ6GRVFE_
M#R3PKJUY#=(+^;5_+N$B_/\ %<-YUF/&F,RC.\[P57-(XNK#'YKC96E.@E#V
M;<H2BI.$K-V@E))17+9R/KL!FV6Y?P_A,5@\'-4ZL7*&&PR;7M.1R:2:=D^F
M]MKV/ZXC?V8D2%KJ!)I 3' \BI.X!()2%RLKC(X*J=PY7((-"RQR%MC;L'G
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M,WBO4?%G@;5K3_0?#/C;7=02Z?3M'UA3>S6(MD$LB23K)-''+_8;A_7]#_\
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MYT7,:2!9YP(K>5HY)$22""*6>2[A;)G\P",.R[#_ !@_\%+?^#=CXN7?Q/\
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6'\J** %HHHH _]D!              $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139989962337584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIQUIDIA CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001819576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-1710962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">419 Davis Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Morrisville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">328-4400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LQDA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tm2219020d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lqda-20220615.xsd" xlink:type="simple"/>
    <context id="From2022-06-15to2022-06-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819576</identifier>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-06-15to2022-06-15">0001819576</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-06-15to2022-06-15">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-06-15to2022-06-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-06-15to2022-06-15">2022-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-06-15to2022-06-15">LIQUIDIA CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-06-15to2022-06-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-06-15to2022-06-15">001-39724</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-06-15to2022-06-15">85-1710962</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-06-15to2022-06-15">419 Davis Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-06-15to2022-06-15">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-06-15to2022-06-15">Morrisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-06-15to2022-06-15">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-06-15to2022-06-15">27560</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-06-15to2022-06-15">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-06-15to2022-06-15">328-4400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-06-15to2022-06-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-06-15to2022-06-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-06-15to2022-06-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-06-15to2022-06-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-06-15to2022-06-15">Common stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-06-15to2022-06-15">LQDA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-06-15to2022-06-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-06-15to2022-06-15">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-06-15to2022-06-15">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MC9AM;_(V%(;_BI5)TR:U)4YY[0")0KNQIZ6TT#W2IGTPB0&KB<UL!]I_O^-
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M"^#\4BG[N>-6^/D'FOZ_4$L#!!0    ( .$[UE2?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( .$[UE0'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ X3O65$^RR7ON    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ X3O65)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #A.]94<.8A@'0$  "L$0  &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ X3O65)^@&_"Q @  X@P   T              ( !MPP  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #A.]94EXJ[',     3 @  "P
M@ &3#P  7W)E;',O+G)E;'-02P$"% ,4    " #A.]94JL0B%C,!   B @
M#P              @ %\$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MX3O65"0>FZ*M    ^ $  !H              ( !W!$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ X3O65&60>9(9 0  SP,  !,
M             ( !P1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  "Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2219020d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://liquidia.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2219020d1_8k.htm">tm2219020d1_8k.htm</File>
    <File>lqda-20220615.xsd</File>
    <File>lqda-20220615_lab.xml</File>
    <File>lqda-20220615_pre.xml</File>
    <File>tm2219020d1_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2219020d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2219020d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lqda-20220615_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lqda-20220615_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lqda-20220615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lqda",
   "nsuri": "http://liquidia.com/20220615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2219020d1_8k.htm",
      "contextRef": "From2022-06-15to2022-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://liquidia.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2219020d1_8k.htm",
      "contextRef": "From2022-06-15to2022-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://liquidia.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-22-073264-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-073264-xbrl.zip
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MF!^ -Q1'^?_#MH&\7!H-+]?4R[]02P,$%     @ X3O65&V'L-W_"@  ;(<
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M.K=< #;;8&BB@,BP.P/0J,2H4",A]P;''4\VF.\72=33;9A"MWA 1MM\Z*J
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M:!Z R="'B!1DLA>L,M W7PL2;45_N9\>KY9)GMI./$V)L_X),%?W3EIZ$'P
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MOV42O7NV +I5[U.3]N](":R(:YO<.";Z83"2>EZ,GJ/=R;G\+[!J\&FT-.2
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M;/D0/)4NN6FEPH/YV1?=TM<Y"7FVX+0&FQNK=1_/?U.!A"^=@HP &)@),2@
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M %*GA>ND)^0WSE[:^0>OX@YN@_GMP6M6G[YV-?3!P8JQ7V3IZ;=G)S97TF)
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M0H5Z=?.=,,(.CK+4X&UL4"1ZI[<E/73$%V_-O:FX-Q!_-NNE)4+"![DK[NH
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MU$R(1X"8&W8V_UM]'//JP^U:5ZK+/=DB]0BJ4^CZ[>CXA2;+F_62Q:\Z);]
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M-88RF90*F&>OHG(6R-[1;_FZ;$Q=)]4;/^%J8#PWBK$E]Z.A<C8I1M^R!%H
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M9Y=CLTT@H@O?6LZ!,CG9RSJNJL2F^<?LGQVE= .<,]\FGMB'&,+D?<2GF\3
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M(_[=I(S9@4E-U_XPL9X<5QD(%1?,U7O1!L82XIK061\5\S2I#/.;%MG3#OS
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M:.:9%BGA C?FJN1EJ%3DTS=('[ :=N(E(M@RLGU;C>O32128,<RUQ6U_P67
M68XH+"1P\+_0W? X7'(]3;;PLZ)2S^*RC/.Z#\DPM;43._FV5K?*HR,4.FIH
M=7>Q1:3LD2J]++=H-4VV/^L:)MW_W-9J 1Y]9<<SZY2#R*9>7!:AV;KYNIY8
MIO@/KB=[*0T8ZG":CAO.X? ]KF;C%U(D@3-^QP:O2Q<L66+)%?.6W P'Y/:=
M _+Z')"/[AR0=QB\&R$M+G4S/6FG]>&F0+FS$P9CM/+<5,@S&(#T'!'@'B-!
MF^W(.06@GDXF@9^@][IP.A7K,GI5\470=5[ R.8T-ZGNQ_X*@;S9-]U=*HF)
M\#N,/=O&.7KP?,EFS8*N%6?H!\U[0%UC7("X%$]L_RP"01,VV;U$VBS0AOQO
MCX)#"$BJQ6%4*4K<B_^"HY2Q])H@8$;M8(82:*Q6B2+'XD#C:W:&<CXEIWSY
M<63#ZN+=Q<J9!(30T#4*-@S)MQ.<"O1?Z-74\:Y%V<X:Z'4[#E$G P\-&[I1
M>*^1RE)PG6N45*9=6$T5$+( S.--D/BM.2<0:JFXGNCW G;SZZ_ID.BH_, J
MZF.$:&EN@- C@1 ="[4(Z?L_]*"W.UQ@2.30+CUFD%Z+',SS$9M<8!BP2&Z,
MN>26F&S*HZ8YO5ZF>_AG\-; P=?#MW;K)WD;4QQOMD@KA2OIM4H=+U9A\ B8
M$@5960Y-1X_$Y%4"+_-DJ'#G1(8ZQP@I=L:JE.)_T[ :N!383^=Q-WF)]OA)
M4G(3(4_4C%9QC"A+E6"K+<64;7AD6(E/$V./GTO67#]3H)V''_&0\?H/191W
MB$N=7[1G*T3>3N#PBW?1>&N8+%A!W1I5#%*$B7]B[>TE('F#QX33:J4E;CD!
MOV!K1=[.:M-C60>:[9WM+^!-U":4#P,HNHRAO1GMVG32,5=([<JU7@B969RE
MM'.13_?F3ZWU$WW! BJ("8L(,?P\2*4HE+F-K$7[X#2>)P:E"G_8?!J3CC1*
M&K8<%217TD/XA:3LC@"#G\3#4CD$15N)9D4V]G>-(:GCZT"AL!Y6_GMT)] X
MT0X[C+H-L6MOU:;P8? H5)+;,"\RVCVE))V<P2TX07U;T&30_K>]2+TL@IE
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M_>BU<=)O>,C[;1P!A5_6R(G^@$-I85P"U*#E"3 2].5YB9N#/U$EM$>H&4A
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MC!PSE);#[.T*?[NW/S?Y<KS$=M_>6KS?GR.)U6?-6Z;<^,G"/<B/RECF<?V
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M?>?*N7/EW AQT;^M7[Y^=?3FU[VWO]/9W47ZR*T9P5+3$,X,Q\.:ULE,J)E
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MQJ_'O[U_]?\#4$L! A0#%     @ X3O65/)S!#<\ P  ]0L  !$
M     ( !     &QQ9&$M,C R,C V,34N>'-D4$L! A0#%     @ X3O65&V'
ML-W_"@  ;(<  !4              ( !:P,  &QQ9&$M,C R,C V,35?;&%B
M+GAM;%!+ 0(4 Q0    ( .$[UE1EPZT-5@<  ,%8   5              "
M 9T.  !L<61A+3(P,C(P-C$U7W!R92YX;6Q02P$"% ,4    " #A.]941? _
MSF(>   >D@  $@              @ $F%@  =&TR,C$Y,#(P9#%?.&LN:'1M
M4$L! A0#%     @ X3O65-*_:>TO;0  R'<" !8              ( !N#0
M '1M,C(Q.3 R,&0Q7V5X,3 M,2YH=&U02P4&      4 !0!) 0  &Z(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
